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CHAPTER I INTRODUCTION 
INTRODUCTION 
Traditional medicine is the sum total of the knowledge, skills and practices 
based on the theories, beliefs and experiences indigenous to various culture, whether 
explicable or not, used in the maintenance of health as well as in the prevention, 
diagnosis, treatment or improvement of physical and mental illness 
(www.who.in/medicine.accessed). Traditional medicine (TM) is a term used to indicate 
both to systems such as traditional Indian Ayurveda, Chinese medicine and Arabic 
unani medicine, and to various forms of indigenous medicine. In countries where the 
outmost health care system is based on allopathic medicine, or where TM has not 
been  implemented  into  the  national  health  care  system,  TM  is  often  termed 
"complementary", "alternative" or "non-conventional" medicine . 
The connection between TM and biodiversity are exemplified as earth’s natural 
system along with heritage of healing powers, whether this involve medicinal plants 
and animal species, the ambient invigorating air, spring water or the natural scenery. 
The pharmacopoeia of folk seties as well as other medical systems like Ayurveda, 
Chinese,  biomedicine  and  Unani  contains  thousands  of  medicament  from  herbs, 
leaves, bark, roots, animal, mineral substances and other materials which are found in 
nature (Geslar, WN 1992). 
TRADITIONAL MEDICINE ALL OVER THE WORLD: 
Plants have been one of the important sources of medicines since the beginning 
of human civilization. For instance, the Chinese drug Mahung was being used for over 
5000years for the treatment of different types of fever and respiratory tract disorders. 
African Traditional Medicine (ATM) provides holistic treatment. The medicament which 
was  used  in  Africa  can  be  administered  in  the  form  of  decoctions,  infusions 
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etc.(liquid), powder (solid), balsam (semisolid) or steam inhalation, incense etc. (gas). 
The only route of drug administration which is not present in TM in Africa is the 
intravenous route. E.g., Ageratum conyzoides is commonly used in TM for dressing 
wounds and ulcers, for cabbies and as an eyewash, Zanthoxylum zanthoxyloides a 
chewing  sticks  shows  antimicrobial  activity  against  oral  micro  flora,  Rauwolfia 
vomitora roots in treating some mentally ill patients etc. Along with TM, the western or 
allopathic systems were followed in India and Pakistan. Their traditional medicine is 
divided into two types a) Unani and b) Ayurvedic. Both these systems have their from 
Mediterranean. Tibb is another system which was a combination of Hindu and Muslim 
system, was brought in to Unani systems. Hence this is known as Unani-Tibb or 
simply as Unani. ‘Hakims’ are the traditional healers of Unani and have used St. 
John’s wort in their remedies for run down conditions and depressions. 
For thousand years ago, the knowledge of medicine on Indian subcontinent is 
termed as Ayurveda. Ayurveda still remains as the most important system of medicine 
and drug therapy in India. The Materia medica of all these medical systems consist of 
many herbs made into pills, syrups, confections and alcoholic extracts, and also some 
metals (Evans, WC 2009). Siddha is the system found with Dravidian culture of 
prevedic period which is largely therapeutic in nature. The causative factors of the 
disease is identified through pulse reading, body colour, voice study, examination of 
urine and tongue examination (Kokate, CK, et al., 2006). 
FUTURE OF TRADITIONAL MEDICINES: 
By looking forward, it is very clear that rich collaboration of traditional and 
allopathic system of medicine benefits both disciplines. There is growing interest in 
this partnership, as shown by number international journals now dedicated to such 
research,  such  as  Complementary  Therapies  in  Medicine,  CAM,  Alternative  and 
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Complementary Medicine (Singh seema, 2007). Even the WHO has taken note of the 
rich possibilities of the future of TM, having put out such documents as 2018 Who 
General Guidelines for Methodologies on  Research and Evaluation of Traditional 
Medicines. It is well established that TM plays a vital role in health care for a greater 
part of the population living indeveloping countries. For centuries, TM was the one 
and only health care system used to the prevention and treatment of diseases in 
various cultures. The interfaces among public health, TM and biodiversity 
conservation encompass a number of relevant and contemporary issues which are 
becoming increasingly apparent, as exemplified by WHO's aim in medicines: "To help 
save lives and improve health by ensuring the quality, efficacy, safety and 
rational use of medicines, including traditional medicines, and by promoting 
equitable and sustainable access to essential medicines, particularly for the 
poor.” 
USES OF HERBS IN TM 
Numerous case series and reports of heavy metal poisoning associated with 
the use of Traditional Chinese Medicines (TCMs) have been published in WHO. WHO 
has  insisted  the  usefulness  of  scientific  investigations  into  indigenous  herbal 
medicines, and many countries look into their native medicinal plants as possible 
additions to the WHO list of "essential drugs", once their value has been proven 
clinically. It is known that several infectious diseases can be transmitted from animals 
to humans (i.e. zoonoses). Hence, the possibility of transmitting infections or ailments 
from animal preparations to the patient should be considered seriously. Many tissues 
and organs including bones and bile can be a source of Salmonella infection which 
causes chronic diarrhoea and endotoxic shock. From the traditional scientific study of 
remedies, a large number of natural products have come to us and most of them 
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being plant derived. It is widely accepted that the presence of a biologically active 
constituent(s) in a plant is from folk or from ethno medical information. In other words, 
folk or ethno medical information represent ‘leads’ that could shortcut the discovery of 
modern medicines. A significant portion of the currently available natural and/ or 
semisynthetic pharmaceuticals in clinical use consist of drugs which is derived from 
higher  plants  followed  by  microbial,  animal  and  mineral  products,  in  that  order 
(Remulo, RN 2007). 
ETHNOBOTANICAL EVALUATION: 
The  primitive  societies  for  their  health  management  treatment  of  various 
diseases depended on herbal remedies from time immemorial, which was developed 
by  observations,  trail,  error  and  experimentation  methods.  India  with  vast  ethnic 
groups with rich biodiversity has centuries of old ethno botanical heritage for the 
promotion of health and treating minor illness. The scope, concepts and implication of 
ethno botany have been very fastly expanding and their knowledge has practical 
relevance for searching new sources of herbal medicines. During the last decades, a 
procession  of  so  called  wonder drugs  eg. Reserpine,  rescinnamine,  quinine, 
ephedrine, cocaine, emetine, khellin, colchicine, digoxin, artemisinin, 
phodophyllotoxin, gugulipid, taxols, ajmalicine, vinblastin,vincristine etc. have been 
discovered from ethno medicinal plants with rich ethno botanical lore in tribal and 
aboriginal societies. 
CONTRIBUTION OF MEDICINAL PLANTS: 
Herbal drugs constitute the main stay of complementary medicines. As the cost 
of most of the western medicines lies beyond people’s affordability, millions of world 
population in the developing countries solely depends on herbal medicines. Since the 
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population of herbal medicines is increasing in developing countries, herbal drugs are 
now entering the mainstream of medical care (Mukerjee, PK et al., 2003). 
Alternative therapies include homeopathy, acupuncture, energy healing, herbal 
medicines, folk medicines, and message to name only a few. Millions of people have 
used and will always use herbal drugs because they have faith in them and regard 
them as “their’ medicine, in contrast to the “allopathic” system of medicine brought in 
from “outside”. The traditional practitioners of medicine who are the part of community 
prescribe medicinal herbs which are locally available and the patient feels comfortable 
in their presence (Manuchari, EB et al., 2001). 
Herbal drugs which formed the fundamental of health care all over the world 
since  the  earliest  days  of  mankind  are  still  being  used,  and  have  considerable 
importance in international trade. Clinical,  pharmaceutical and  economic value  of 
herbal drugs are still growing, although this differs widely between countries. 
RESURGENCE OF HERBAL DRUGS: 
Still now a large proportion of the rural population depends on herbs as medicine 
for  the  treatment  of  diseases  because  of  its  availability  and  affordability.  The 
importance of medicinal plants and traditional health systems in solving the health 
care problems of the world is gaining increasing attention. Because of this resurgence 
of interest, the research on plants of medicinal importance is growing phenomenally at 
the  international  level,  often  to  the  detriment  of  natural  habitats  and  mother 
populations in the countries of origin. Most of the developing countries have adopted 
medical practice as an integral part of their culture (Farnsworth, NR et al., 1991). 
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CREDITS  OF  HERBAL  MEDICINES  OVER  MODERN  SYSTEM  OF 
MEDICINE: 
Natural products like plants, animals and minerals have been the basis on the 
treatment of human diseases. Modern medicine or Conventional Western System of 
Medicine has gradually developed due to the efforts of scientists – however, the basis 
of its development remains in the roots of TM and therapies (Bhusan, P 1992). A large 
number of drugs have come out from Ayurvedic experimental base e.g. Rauwolfia 
alkaloids  -hypertension,  Psovalens  -  vitiligo,  Holarrhena  alkaloids  -amoebiasis, 
Guggulsterons - hypolipidemic agents, Mucuna pruriens - Parkinson, Piperidines - 
bioavailability enhancers, Baccosides - mental retention, Picrosides- hepatic 
protection, Phyllanthins - antivirals, Curcumines - inflammation and so on. 
DRUG DISCOVERY FROM MEDICINAL PLANTS: 
Based on the information obtained from the traditional practitioners roughly 121 
pharmaceutical products have been discovered during the last century. The best 
example is periwinkle, well known example of African plant used in African Traditional 
Medicine  for  diabetes.  The  traditional  use  of  the  plant  had  led  to  commercially 
marketed product Convinca in South Africa and Inclusion in England for treatment of 
diabetes. Based on the uses of Catharanthus roseus as a folk cure for diabetes, Eli 
Lily Company during 1950s discovered its well-known cancer alkaloids (Boer de, HJ 
2008). 
Considerable research on Pharmacognosy, phytochemistry, clinical 
therapeutics  and  pharmacology  has  been  worked  out  on  herbal  plants.  Several 
preclinical and clinical studies have examined cytoprotective, immunomodulatory and 
immuno adjuvant potential of Ayurvedic medicines. The development of TM with the 
DEPARTMENT OF PHARMACOGNOSY, MMC, MADURAI Page 6 
CHAPTER I INTRODUCTION 
prospective  of  efficacy,  safety,  and  quality  will  not  only  preserve  the  traditional 
heritage but also to use of herbal products in the health care. 
HIGH-THROUGHPUT SCREENING (HTS) IN THE NEWER DRUG 
DEVELOPMENT: 
HTS techniques are used mostly in the pharmaceutical industry in support of 
lead  projects  whose  aim  is  to  efficiently  sort  through  enormous  numbers  of 
compounds  for  leads,  the  starting  chemical  structures  for  the  drug  development 
process. Organic small molecules from large libraries or natural products are batch- 
tested against biological targets in industry using standard 96- and 384-well plates, 
sometimes even higher density 1536- or 3456-well plates. As automation and robotics 
are increasing throughput ranges from thousands to ten lakhs samples tested per day 
which depend on the specific assay. Rate-limiting steps required for the assay often 
lie in the type of signal detection; simple fluorescence signals on the top end and 
cellular imaging assays at the bottom end of the throughput range. Although a lot of 
chemicals required to screen toxicity for lead generation is not in the range of the 
numbers of chemicals typically screened for drug discovery, the opportunity to broadly 
make an outline of compounds for toxicity with various assays efficiently and cheap 
cost makes an attractive approach for HTS. Therefore few chemicals investigated 
against a large number of assays, is the converse of the drug molecule discovery 
paradigm where many molecules were examined against one biological target. 
(Houck, KA 2008). 
HIGH THOUGHPUT SCREENING in Vivo studies 
In vitro screening method is based on simple interactions of chemicals with a 
drug target e.g. receptor binding or enzyme activity inhibition. As the complicated 
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physiological environment is not found in the in vitro systems, hence in vitro results 
poorly correlate with in vivo results. Even though cell-based assays provide reliable 
results, cultured cells do not give physiological environment and interaction between 
different cell types and tissues. Human tissues are now being used for drug discovery 
research.  Even  tissues  provide  an  isolated  ex  vivo  condition,  it  is  not  complete 
representative of in vivo response as the action of drug involves metabolism and they 
interplay among different tissues. For example, drug acting on muscle may involve 
intestinal absorption and metabolism by the liver. 
Therefore  results  in  animal  studies  are  important  to  validate  HTS  (high- 
throughput screening) hits and exclude molecules with unfavorable ADMET 
(Absorption, Distribution, Metabolism, Excretion, and Toxicity) properties, which are 
responsible for more than half of compound attrition in expensive clinical trials. 
Currently,  in  vivo  studies  are  not  usually  done  until  or  after  the  lead 
optimization stage. This is partly due to the low speed and high cost of animal models 
(typically rodents) and also due to high number of preliminary hits from HTS. As the 
small-animal models are emerging, it is now possible to perform in vivo testing .So 
researchers have developed animal model systems using both vertebrates like zebra 
fish and invertebrates like the fruit fly, Drosophila melanogaster and nematode like the 
Caenorhabditis  elegans  for  drug  screening.  The  small  size,  high  fertility,  and 
experimental tractability of these animals make a cost-effective and rapid screening of 
enormous compounds (Mac 2004). 
BIOFLAVONOIDS: 
Phenolic  compounds  constitute  one  of  the  main  classes  of  secondary 
metabolites. They display a large range of structures and they are responsible 
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for the major organoleptic characteristics of plant-derived foods and beverages, 
particularly color and taste properties and they also contribute to the nutritional 
qualities  of  fruits  and  vegetables.  The  most  important  natural  pigments  are 
carotenoids  which  are  tetrapyrrole  derivatives  of  naturally  occurring  phenolic 
compounds ubiquitously distributed in plant kingdom. 
Among  these  compounds,  flavonoids  constitute  one  of  the  most  ubiquitous 
groups of all plant phenolics. So far, over 8,000 varieties of flavonoids have been 
identified1. Until ~50 years ago, information on the working mechanisms of flavonoids 
was scare. But it has been widely known for centuries that compounds of plant origin 
possess a broad spectra Like as phenolic acids, flavonoids are secondary metabolites 
of plants with polyphenolic structure. They are synthesized by the polypropanoid 
pathway and the startup component is phenylalanine molecule. The biological effects 
of these compounds vary. All flavonoids share the basic C6-C3-C6 structural skeleton, 
consisting of two aromatic C6 rings (A and B) and a heterocyclic ring (C) that contains 
one oxygen atom um of biological activity. 
Flavonoids and phenolic acids make up one of the most pervasive groups of 
plant phenolics. Due to their importance in plants and human health, it would be 
useful  to  have  a  better  understanding  of  flavonoid  concentration  and  biological 
activities  that  could  indicate  their  potentials  as  therapeutic  agents,  and  also  for 
predicting and controlling the quality of medicinal herbs. Plants and herbs consumed 
by  humans  may  contain  thousands  of  different  phenolic  acid  and  flavonoid 
components. The effect of dietary phenolics is currently of great interest due to their 
antioxidative and possible anticarcinogenic activities. Phenolic acids and flavonoids 
also function as reducing agents, free radical scavengers, and quenchers of singlet 
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oxygen  formation.  In  addition,  flavonoids  and  phenolic  acids  components  play 
important roles in the control of cancer and other human diseases. 
EFFECT ON CARDIOVASCULAR SYSTEM: 
Vasorelaxant agent 
The  consumption  of  flavonoids  may  prevent  endothelial  dysfunction  by 
enhancing  the  vasorelaxant  process  leading  to  a  reduction  of  arterial  pressure. 
Endothelial dysfunction represents a critical event in the development of 
cardiovascular diseases and the major complication of atherosclerosis and arterial 
thrombus  formation.  The  consumption  of  flavonoids  can  prevent  a  number  of 
cardiovascular diseases including hypertension and atherosclerosis. Recently, many 
experimental studies have shown that these polyphenolic compounds may reduce the 
arterial pressure in rats and enhance the vasorelaxant process. The endothelium- 
dependent relaxation induced by flavonoids has been well documented. Furthermore, 
Also investigators have demonstrated that Anthocyanin delphinidin exerts a significant 
endothelium dependent vasorelaxation. 
Antiatherosclerotic effects 
Oxidative modification of low-density lipoproteins (LDL) by free radicals is an 
early event in the pathogenesis of atherosclerosis. The rapid uptake of oxidatively- 
modified  LDL  via  a  scavenger  receptor  leads  to  the  formation  of  foam  cells. 
Flavonoids may directly scavenge some radical species by acting as a chain braking 
antioxidant.  The  ability  of  quercetin  and  the  quercetin  glycosides  to  protect  LDL 
against oxidative modification has shown a significant protective demonstrated that 
Anthocyanin delphinidin exerts a significant endothelium dependent vasorelaxation. 
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Antithrombogenic effects 
Platelet  aggregation  plays  a  pivotal  role  in  the  physiology  of  thrombotic 
diseases.  Activated  platelets  adhering  to  vascular  endothelium  generate  lipid 
peroxides  and  oxygen  free  radicals  which  inhibit  the  endothelial  formation  of 
prostacyclin and nitrous oxide. It was shown in the 1960s that tea pigment can reduce 
blood coagulability, increase fibrinolysis, and prevent platelet adhesion and 
aggregation.  Selected  flavonoids  such  quercetin,  kaempferol  and myricetin  were 
shown  to  be  effective  inhibitors  of  platelet  aggregation  in  dogs and  monkeys. 
Flavonols are particularly antithrombotic because they directly scavenge free radicals, 
thereby maintaining proper concentration of endothelial prostacyclin and nitric oxide. 
One study showed that flavonoids are powerful antithrombotic agents in vitro and in 
vivo because of their inhibition of the activity of cyclooxygenase and lipoxigenase 
pathways. 
Cardio protective effects 
Recent  interest  in  flavonoids  has  been  stimulated  by  the  potential  health 
benefits arising from the antioxidant activity of these ploy phenolic compounds. These 
are the result of their high propensity to transfer electrons, chelate ferrous ions, and 
scavenge reactive oxygen species58. Because of these properties, flavonoids have 
been considered as potential protectors against chronic cardio toxicity caused by the 
cytostatic drug doxorubicin. Doxorubicin is a very effective antitumor agent but its 
clinical use is limited by the occurrence of a cumulative dose-related cardio toxicity, 
resulting in, for example, congestive heart failure (negative inotropic effect). In a recent 
report, the cardio toxicity of doxorubicin on the mouse left atrium has been inhibited by 
flavonoids, 7- monohydroxyethylrutoside and 7’,3’,4’-trihydroxyethylrutosid. 
DEPARTMENT OF PHARMACOGNOSY, MMC, MADURAI Page 11 
CHAPTER I INTRODUCTION 
ZEBRAFISH : A POWERFUL ANIMAL MODEL ORGANISM: 
A powerful vertebrate model system is the zebra fish which has been used  for 
the developmental pathways in  genetic analysis and  is only beginning to be 
exploited as an efficient model for human disease and clinical research. Hence this 
attribute have led to the usage of zebra fish as a preeminent embryological model, for 
forward and reverse genetic analyses which provides a unique way to uncover novel 
insights into the molecular genetics of cancer. The advantages of the zebra fish as an 
animal model system include fecundity, with each female capable of laying 200–300 
eggs /week, external fertilization that permits manipulation of embryos ex utero, and 
rapid  development  of  optically  clear  embryos,  which  makes  to  observe  the 
developing internal organs and tissues in vivo directly (Berghmans, S, et al., 2005). 
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LIFECYCLE OF ZEBRAFISH 
CAUSES OF VARIOUS CHRONIC DISEASES 
Various animal experiments have been developed to find out the effects of 
drugs on living organisms, dispersed cells and isolated tissues these give an idea 
about where and how a drug acts. The subject of ‘Drugs’ is as old as disease. From 
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the  beginning  of  his  existence  illness  has  been  his  heritage  and  the  search  for 
remedies to combat it is equally old (Satoskar, RS et al., 1997). For the survival of 
every individual and species, adequate nutrition is a fundamental requirement which 
remains  the  dominant  activity  in  the  lives  of  most  creatures.  In  recent  decades, 
economic improvement has been rewarded by plentiful nutrition unknown to previous 
generations, which has led to a pandemic of obesity with its serious consequences of 
health. Famine and malnutrition is still present for the less economically successful 
which is a huge global burden. Quantity as well as quality of food influences one’s 
health.  Inappropriate  dietary  intakes  have  been  linked  with  various  diseases  like 
coronary heart disease and cancer mainly in developed countries. 
According  to  law  of  thermodynamics,  energy  balance  is  achieved  when 
energy intake is equal to energy expenditure. The Basal Metabolic Rate defines 
the obligatory energy expenditure which is required to maintain all metabolic functions 
in tissues and hence to sustain life (Nicholas, A, et al., 2006). 
COMPLICATIONS OF OBESITY: 
Obesity is discouraged by the present modern generation for social as well as 
medical reasons. The incidence of diabetes mellitus, angina pectoris, 
hypertension, and myocardial infarction is higher among the individuals with 
obesity has increased dramatically in recent years for unclear reasons. Possible 
reasons include the automobile, the internet, television, a decrease in school based 
physical activity programs, fast food etc. 
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ENVIRONMENTAL 
CULTURE 
GENETICS PSYCHOLOGICAL 
OBESITY 
DISORDER 
ENDOCRINE 
DISORDERS MEDICATIONS 
A growing number of medications cause weight gain in some or most of those 
patients from whom they are prescribed. Obesity gives rise to increased CVD risk by 
aggravating some of the CVD risk factors; including high blood pressure, low HDL 
cholesterol, insulin resistance and hypertriglyceridemia. 
UNMODIFIABLE CARDIOVASCULAR DISEASE RISK FACTORS 
Several CVD risk factors are essentially immutable, including older age, male 
gender, and a family history of CVD. Nonetheless, these risk factors are important to 
consider in evaluating risk in an individual patient. 
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RISK FACTORS 
1. Cigarette smoking 
Cigarette smoking along with hypertension and dyslipidemia, is Considered as 
one of the three major risk factors for Coronary Heart Disease (CHD) thromboembolic 
stroke and peripheral arterial disease (PAD). 
2. Dyslipidemia 
Dyslipidemia is probably a better term than hyperlipidemia because it includes all 
lipid and lipoprotein abnormalities, such as high level of low-density lipoprotein (LDL) 
and cholesterol, which can be a potent risk factor for CVD, with a strong dose-response 
relationship that is exponential at higher levels of cholesterol. Even though much of the 
inter individual variability in cholesterol is genetic, dietary intake of cholesterol, saturated 
fat, and trans-fatty acids increases the blood cholesterol. Total cholesterol is carried on 
three lipoproteins in the blood, resulting in three separate cholesterol fractions with 
differing prognostic significance: 
1) Very low-density lipoprotein (VLDL) cholesterol 
2) Low-density lipoprotein (LDL) cholesterol 
3) High-density lipoprotein (HDL) cholesterol 
LDL cholesterol is positively related to CVD incidence and HDL cholesterol is 
inversely related. 
3. Hypertension 
Blood  pressure  can  be  increased  by  a  number  of  mechanisms.  Increased 
relaxation and increased cardiac output may all contribute to hypertension in obesity. 
Renal sodium absorption is increased in patients with hyperinsulinemia which has been 
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proposed  as  a  causative  to hypertension  in  obesity  via  increased  circulating  blood 
volume. Abnormalities of vascular resistance may also contribute to the 
pathophysiology of obesity related hypertension. Under some experimentation 
conditions, elevated FFA levels have been found to cause increased vasoconstriction 
and  reduced  NO-mediated  vasorelaxation,  similar  to  that  seen  in  the  metabolic 
syndrome.  It  has  also  been  suggested  that  there  is  an  increased  activity  of  the 
sympathetic nervous system in some obesity phenotypes, and that this contributes to 
obesity related hypertension (Goldman, L et al., 2004). 
TRADITIONAL MEDICINE TO MEET REQUIREMENTS OF BOTH 
DEVELOPED AND DEVELOPING COUNTRIES 
Traditional medicine can provide new inputs into the drug development strategy. 
For example the Medical Research Council of South Africa carried out an investigation 
on traditional medicine used by communities for the treatment of fevers with the aim of 
invention of new drug leads to treat malaria. 
One such strategy of CSIR involves a method called as “reverse pharmacology” 
in  which  starting  with  natural  products  and  work  backward  to  identify  its  active 
ingredients. So it is vital to consider the relative effectiveness of hese approaches to 
generating cost effective, safe herbal products for poor people. 
REASON FOR  THE STUDY AND SELECTION OF THE PLANT: 
Based on the above discussions we focus our study to utilize the vast economic 
potentiality  of  a  crop  which  can  be  fully  established  by  its  vast  consumption,  then 
employment generation for an agriculture worker throughout the year. It is evident that 
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there  is  good  level  of  experimental  evidence  to  support  claims  and  advantages  of 
various medicinal herbs used in our traditional diet and medicines. In this view we 
selected the widely available and neglected plant “Balloon vine” leaf   Cardiospermum 
halicacabum. for our study. 
The Plant is popularly known as Heart pea, Puff-ball, Heart seed Vine, Love in a 
puff. The scientific name of balloon vine is Cardiospermum halicacabum belong to the 
family Sapinadaceae. 
C.halicacabum  L.  a  green  healer  from  backyard  traditionally  used  in  various 
diseases  including  Rheumatism,  Lumbago,  Cough,  Hyperthermia,  Nervous  disease, 
Stifness of limbs and snake bite, etc., Though there is traditional and experimental 
evidences to support various claims and benefits of these plants still it needs proper 
evaluation and exploitation. 
A study aims to scientifically explore its important medicinal uses which have not 
been fully studied is inevitable. These initiated us to investigate the leaves of this plant 
with strict scientific protocols so that the vast economic potentiality of this crop can be 
adequately  established  by  its  consumption,  opportunity  for  an  employment  to  an 
agricultural  worker  throughout  the  year.  Literature  survey  revealed  lacunae  in  the 
pharmacognostic, phytochemical and pharmacological studies in this plant. 
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PHARMACOGNOSY 
TAXONOMICAL CLASSIFICATION ( Anonymous 2011 Floras: Flora of 
China,  Ndatabase (version 2011)  
Kingdom : 
Plantae                         
–plantes,planta,vegetal,plant 
Subkingdom : Viridiplantae 
Infrakingdom : Streptophyta-land plants. 
Superdivision : Embryophyta 
2011Division : 
Tracheophyta-vascular plants, 
tracheophytes. 
Subdivision : 
Spermatophytina-spermatophytes, 
seed plants phanerogames. 
Class : Magnoliopsida. 
Superorder : Rosanae. 
Order : Sapindales 
Family : Sapindaceae –Soapberries 
Genus : Cardiospermum 
Species : 
 
halicacabum 
 
 
 
 
CHAPTER II                                            LITERATURE REVIEW 
 
DEPARTMENT OF PHARMACOGNOSY,MMC,MADURAI Page 20 
 
SYNONYMS (Subramanyam R et al., 2007, Krishna Murti et al.,2010). 
 Synonym of C.halicacabum  C. corundum Lam; C. glabrum Schum. & 
Thonn.; C. inflatum Salisb.; C. microcarpum H.B. & K.; C. microspermum E. Mey; 
C. villosum Mill. ex DC 
VERNACULAR NAMES (Krishna Murti et al.,2010, G.Ponmari et al.,2011, Raza 
S et al.,2013) 
 
       
 
 
 
 
 
 
 
 
ENTIRE PLANT: 
ETHNOMEDICAL USE: 
 Cardiospernum halicacabum decoction used in rheumatism, nervous 
diseases, pain and as diuretic. (Pillai.N.R and Vijayamma.N.,1985). 
 It is used in Rheumatism, Lumbago, Nervous disease, Demulcent inorchitis 
and Dropsy.(Patil et al.,2011).(G.Ponmari et al.,2011). 
 Traditionaly C.halicacabum highly useful in Ayurveda, Sidha, Homeopathy, 
Unani indian system of medicine to treat Rhumatoid Arthritis, GI disease, 
Respiratory disease, Inflammatory disease in India and 
China.(Shekhawat.M.S et al.,2012). 
English : Balloon vein,Heart’s  pea. 
Sanskrit : Sakralata,Indravalli. 
Hindi : Kanphuti,Kapalphoti. 
Bengali : Lataphatkari 
Marathi : kanphuti, shibjal, kakumardanika 
Gujarthi : Ghisoda. 
Telugu : buddakakara, ekkudutige 
Tamil : Mudakattan 
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 This  plant juice is useful in Amenorrhoea,Gonorrhoea,Asthma and 
Nervous system problem.The herbal decoction used for Rheumatism, 
Nervous illnesses, pain and diuretic.(Raza S et al., 2013, Jayabalan.,2006) 
 This plants are used in traditional medicine for treatment of  Rheumatism, 
Lumbago, Cough, Hyperthermia, Nervous disease, Stifness of limbs and 
snake bite.(Jeyadevi R et al., 2013). 
 It is remedy for joint pain.young shoots are used as vegtable, fooder, 
diuretic, stomatchic and Rubefacient. (Shobana Devi.S et al.,2016). 
(shobana devi.S et al .,2016). 
FORMULATIONS: 
 Herbal products from this plant like Gel, Cream, Shampoo,Spray availble in 
market. These are all use to dry itching skin and scalp. Allergic liquid used 
for Hay fever allergies,sneezing,watery eyes and for skin disease such as 
inflammation, scaling, burning and pain. Cream for uing of Rheumatism, 
back ache, Ear ache and fever.(Patil A.G et al .,2010). 
 This plant one of the ingredient in Allergy Relief Liquid and Bioforce 
pollinoson tabs marketed by Bioforce USA.Florasone cardiospermum 
cream for skin ailments by US based company.(Patil A.G et al.,2010). 
PHARMACOGNOSY: 
 Cardiospermum is the combination of the Latin words cardio, meaning 
heart, and sperma, meaning seed and refers to the white heart-shaped 
pattern on the seed .(Plants For A Future, 1996 -2003. Last modified: June 
2004). 
 Synonym of this plant C. corundum Lam; C. glabrum Schum. & Thonn.; C. 
inflatum Salisb.; C. microcarpum H.B. & K.; C. microspermum E. Mey; C. 
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villosum Mill. ex DC.(Subramanyam R et al., 2007,Krishna Murti et al.,2010). 
 Balloon-vine is a perennial creeper at its base, the plant’s stem is only 
approximately 3mm thick, but it can reach a height of up to 2 metres. The 
stem forms internodes of between 5-10 cm in length.The grooved stem 
carries alternate double triad leaves, 3 to 5 cm long, which are hairless or 
covered in a soft down of hairs. The oval or lanceate leaves have a deeply 
serrated or lobated edge. The leaflets at the side are smaller. The tiny 
radiate flowers are white,standing in rolls on long flower stems of 5 to 10 cm 
in length.(Krishna Murti et al.,2010)  . 
 Common names of this plant is Heart pea, Puff-ball, Balloon vine, Heart 
seed Vine, Love in a puff.( Krishna Murti et al.,2010). 
 C.halicacabum, commonly known as Mudakathan in Tamil is also called as 
Kanphuti, Kapalaphoti in Hindi,Uzinja in Malayalam and Balloon wine in 
English which annually spread with tendril hooks.(G.Ponmari et al.,2011). 
 C.halicacabum L. commonly known as "Balloon vine" , belonging to the 
family Sapindaceae.It is dioeecious, hairy climbing vine with balloon cluster 
of white flower and delicate foliage.(Patil et al 2010.,).(G.Ponmari et 
al.,2011). 
 C.halicacabum grows in plains of Africa,America,Bangaladesh,India and 
Pakistan.(Raza S et al., 2013).(Selvarani S,Vinayagamoorthi and Rohini R 
2015),(Dhayabaran D et al., 2012). 
 This plant is pubertal or almost glabrous yearly perpectually having slim 
twigs that climb by tendrillar hooks.( Raza S et al.,2013). 
 It contains 16 species present in Brazil and 12 species are found  in South 
America.This plant is an herbaceous climber 2-4m length,heart shaped, 
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commonly known as balloon vein.(Raza S et al.,2013). 
 In England (Heartpea), Philippines (parol-paralon),China(jiahu gua), 
Tamilnadu-India(Mudakathan keerai).(Raza S et al.,2013). 
 Cardiospermum halicacabum L. locally known as peria bulan in Malaysia . 
(Mohad Norfaizal et al.,2017). 
PHYTOCHEMISTRY: 
 The Pet ether extract of C.halicacabum contained sterols, carbohydrates, 
tannins and triterpenes.(Venkat Rao. N, Chandra Prakash.K,Shanta 
Kumar.SM.,2006). 
 Sodium was not detected in the shoots, but other minerals such as Ca 
(1.30%), K (4.01%), Mg (0.43%), P (0.83%), Organic-N (5.19%), Total-N 
(7.16%), and C (48.1%) were present. (Subramanyam R, et al., 2007). 
 Fingerprint profile of the bioactive Ethanolic extract of C.halicacabum by using 
HPLC , DAD method.In HPLC the mobile phase consist of water and 
Acetonitrile with 1% TFA Gradient program Acetonitrile 5% -25%-30% in 
0-10-30-60 min. flavanoids and phenolic acids were detected by UV at 280 
nm.(Ling cheng et al.,2013, Krishna Murti, et al.,2010). 
 C.halicacabum extracts possessed high phenolic content, and exhibited 
strong free radical scavenging activity and ferric reducing proper(Annamalai 
A, Ponmari G, Sathishkumar Rand Lakshmi P.T.V.,2O11). 
 Beta-Arachidic acid,apigenin,apigenin 7-o glucronides,Chrysoerial-7 
Glucronide and 80  Luteolin 7-o glucronide two crystalline compounds 
beta-sistosterol and beta d-glucoside. Acetic acid,1,6,10-dode catriene,7,11 
methyl-3-methylene ,phenol,2,6 bis methyl methyl carbamate,3-0- 
methyl-d-glucose 1,14-Tetra decanediol, 3,7,11,15,Tetramethyl-2 hexadecan 
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1-ol, Phytol,pseudo ephedrine,2-propenamide are presence in ethanolic 
extract.( Raza S et al.,2013). 
 Rutin also present in this plant,which is a flavanols,quercetin and the 
diasaccharide rutinose.the biological activity of the plant was accounted for by 
saponins, alkaloids (+)-pinitol, apigenin, luteolin, chrysoeriol, quebrachitol, 
proanthocyanidine, stigmasterol, fatty acid, 11 eicosenoic acid triterpenoids, 
glycosides, sterols, tannins and flavanoids. (Raza S et al.,2013). 
 RP- HPLC analysis done by photo iodide arrat Detcetors .Reverse phase  
column 4.6 X 250 nm. 5 micro meter particle size.The mobile phase used as 
water with 0.1 % formic acid(solvent -A) and 100% Acetonitrile( solvent-B) for 
identifying the phenolic compound.(Jeyadevi R et al.,2013). 
 Now 18 Phenolic compounds identified in C.halicacabum using 
UPLC-ESI-Q-TOF-MS/MS.LC/MS/MS indicate presence of phenolic acids 
such as  Chlorogenic acid,Caffeic acid, Coumaric acid and flavanoids like 
Luteoline 7-o glucronide , apigenine 7-0 glucronide and chrysoeriol.(Jeyadevi 
R et al.,2013). 
 17-compounds are present in ethanolic extract of C. halicacabm  1) quercetin 
3-0-alpha - Rhamnoside 2)kaempferol 3-o - alpha-l-Rhamnoside  3)Apigenin 
7-o-beta-d glucronide 4)Apigenin 7-0- beta  d-glucronide methyl ester 
5)Apigeni 7-o - beta d glucronide ethyle ester 6)Chrysoeriol 7)Apigenin 
8)Kaempferol  9)Luteolin 10)Methyl 3,4 dihydroxy benzoate  11)p- coumaric 
acid 12)4-hydroxy benzoic acid 13)quarcetin 14)Protocathehuic acid 15)Gallic 
acid 16)Indole 3-carboxylic acid 17)Hydroquinone.( Ling cheng et al.,2013). 
 The solvents such as butanol,acetone,methanol and petroleum ether of  
C.halicacabum was reported by using preliminary phytochemical 
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analysis,presence of alkaloids,phenols,tannins,saponins,terpenoids and 
glycosides.(Harborne J.B 1998,Sagadevan P et al.,2013). 
 Diethyl ether, chloroform, acetone extracts of leaf, stem and seed coat of 
Cardiospermum halicacabum L. was analysed for the compounds such as 
tannin, saponin, flavonoid, steroid, terpenoids, cardiacglycosides,alkaloids, 
anthraquinones. (Annadurai.A,Elangovan .V,Velmurugan .S and Ravikumar 
R.,2013). 
 Apigenin and Luteolin (secondary metabolites) are present in this plant.It was 
reported by using RP-HPLC method.(Selvarani s,Vinayagamoorthi P,and 
Rohini R 2015). 
 C.halicacabum contains tannins,saponins ,flavanoids,glycosides and Cardiac 
glycosides.Aglycones,Triterpenoids,Varitey of fatty acids ,volatile ester 
confirmed by phytochemical screening.(shobana devi.S.,2016). 
 The phytochemical screening of the plant was reported a positive test for 
presence of various phytoconstituents  like alkaloids,flavanoidsand 
tannins.The amount of total phenol was found to be between 29.697±0.232 to 
187.372 ±0.615 mg pyrogallol eqivalent/g in various extracts.(Mohaddesi 
B,Dudhrejiya A,Chauhan M 2016). 
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    PHARMACOLOGY: 
 Ethanolic extract of this plant affect the adult worm damage.It affect the 
motility of the microfilariae.(Khunkitti w et al.,2000). 
 Cardiospermum halicacabum L. was reported it is a traditional Chinese 
herb (Ë¦a¹a) and found inhibiting histamine release and nitric oxide 
production.( Subramanyam R et al.,2007). 
 The whole plant, roots and leaves of this plant are traditionally used as 
anxiolytic and as anticonvulsant.( Malaviya.S et al.,2009). 
 C.halicacabum was reported to possess Antidiarrhoeal activity ,Antimalarial 
activity, Antiulcer activity, Anti-inflammatory activity.( Krishna Murti et al., 
2010). 
 C.halicacabum entire plant was reported to possess  anti-inflammatory, 
antibiotic against many bacteria, antiparasitic,antipyretic and analgesic.It 
also used to reduce swellings and hardened tumors.It has non toxic 
Antifertility activity.(Patil et al.,2010). 
 Extract of C.halicacabum used as antiulcer analgesic and vasodepresent 
activities.(Chang et al.,2013).(G.Ponmari et al.,2011). 
 C.halicacabum extract was reported to possess high phenolic content, and 
showed strong free radical scavenging activity and ferric reducing property. 
Large quantity of phenolic compounds in C.halicacabum extract create it a 
strong free radical scavenger, which indicates that the extract has good 
potential as a source for natural antioxidants to prevent free radical 
mediated oxidative damage.(G.Ponmari et al.,2011). 
 The hepatoprotective activity for the flavanone from C.halicacabum against 
liver injury induced by a toxic dose of acetaminophen.( Rupeshkumar .M,  
Kavitha.K, Basu.S.K.,2012).         
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 This Plant is reported to possess Anti- inflammatory activity by reducing 
PLA2 activity that is concerned with inflammatory process.The methanolic 
extract of the herb reduced the Hepatitis B surface Antigen (HBsAg).In vitro 
tissue experiment the herb shows Antispasmodic activity.( Raza S et 
al.,2013). 
 Ethanolic extract of this herb is effective against Gastric ulcer in balb-c rats 
the herbal tea increases the blood levels of theophylline, so avoided the 
herbal tea for treated with theophylline because increases the 
bioavailability of the recomendation of the drug.(Raza S et al.,2013). 
 On central nervous system the decoction of this plant showed sedative 
effect. It exhibited significant analgesic and anti-inflammatory activities. 
(Babu, Dr.Suthakaran R, Srinivas Reddy CH.,2014).         
ANTIFUNGAL ACTIVITY : 
 C.halicacabum extract inhibit against the fungi C.albicans .Alcoholic extract 
has high antifungal activity than chloroform.(Raza S et al.,2013) 
ANTIPYRETIC ACTVITY: 
 This plant active against yeast induced pyrexia in rats.( Asha and 
Ushpangadan, 1999).  
 ANTIFILARIAL ACTIVITY: 
 Ethanol and aqoues extrct of this herb used as Antifilarial activity on mature 
worm and microfilariae of Brugiapahangi.( Khunkitt et al., 2000). 
 In vitro effects of ethanol and aqoues extract of the medicinal plant of 
C.halicacabum on adult worm microfilariae of Brugia pahangi.Aqoues  
extract of this plant was reported adult worms were damaged but did not 
affect the motility of the microfilariae.( Veeramani.C et al.,2015)     
 
CHAPTER II                                            LITERATURE REVIEW 
 
DEPARTMENT OF PHARMACOGNOSY,MMC,MADURAI Page 32 
 
ANTI DIARRHOEAL ACTIVITY: 
 The whole plant extracts (i.e. petroleum ether, alcohol and aqueous) of C. 
halicacabum (Linn) contain tannins, flavonoids, saponins, sterols and 
triterpenes, which could have contributed to the antidiarrhoeal activity. 
(Venkat Rao. N, Chandra Prakash.K, Shanta Kumar.SM., 2006, 
Kurian,1995) 
ANTI-INFLAMMATORY ACTIVITY: 
 The anti-inflammtaory activity of ethanol extract against 
carrageenan-induced rat paw edema has been established . The ethanol 
extract of the plant suppresses the production of TNF-_ and nitric oxide in 
human peripheral blood mononuclear cells (Sheeba.M.S, Asha.V.V.,2009, 
Selloum et al., 2003) 
ANTIMICROBIAL ACTIVITY: 
 Acetone, alcohol, benzene, chloroform and aqueous extracts of leaf and 
stem of C.halicacabum have antimicrobial activity. (Viji.M, Murugesan.S., 
2010). 
 The antimicrobial activity of different fractions and oil of Cardiospermum                 
halicacabum against twelve Gram positive and negative bacterial strains. 
Cardiospermum halicacabum represents strongest antibacterial activity 
against Salmone paratyphi B. (Shareef.H et al.,2012). 
 The herbal leaf extract possesses antimicrobial activity against certain 
bacterial species i.e. Staphylococcus aureus, Bacillus subtilis and 
Escherichia coli and more useful against E. coli (Deepan et al., 2012). 
 Diethyl ether, chloroform and acetone extracts of seed coat of this plant 
have maximum inhibitory  zone and chloroform extract of this plant stem 
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have a maximum inhibitory zone in pseudomonas. (Annadurai.A et 
al.,2013). 
 C.halicacabum used as antimicrobial,anticancer,antiparasitic,antimalarial 
and antifilarial activity.Aqoues extract of this plant has antimicrobial 
activity,it active against Escherichia coli.Ethanolic extract of this plant has 
antimicrobial activity, it active against Staphylococcus areus (Gram positive 
bacteria). (Selvarani.S,Vinayagamoorthi.P,and Rohini.R et al., 2015). 
 Now days its used as a antibacterial activity.It was reported active against 
clinical human bacterial pathogens. 
 Butanol extract  →  stem and root 
 Acetone extract  →  leaf and root 
 Methanol extract → seed 
 Acetone extract has the highest antibacterial activity compare than 
methanol and petroleum ether.(Selvarani.S et al., 2015). 
ANTI HYPERGLYCEMIC ACTIVITY: 
 Anti-hyperglycemic effects against streptozotocin induced diabetic male 
Albino rat.Ethanollic extract of C.halicacabum supress the production of 
TNF alpha and NO in human pheripheral blood mono nuclear cells.This 
plant has antioxidant activity because of presence of phenolic 
compounds.(jeyadevi R et al.,2013). 
 The juice of the herb is used to cure ear-ache and to reduce hardened 
tumours. . (Veeramani.C et al.,2015). 
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AERIAL PART 
PHARMACOLOGY: 
ANTI-INFLAMMATORY ACTIVITY: 
 By rat- paw edema method( 500 mg/kg) transudative exudative and 
proliferative components supression of chronic inflammation.(Raza S et al., 
2013). 
ANTIMICROBIAL ACTIVITY: 
 aerial parts have reported different biological activities like antimicrobial 
and antibacterial properties.(Mohaddesi.B,Dudhrejiya.A,Chauhan.M et 
al.,2016).    
LEAF: 
ETHANOMEDICAL USE: 
 Decoction of leaf with jaggery and pepper is used for fever associated with 
cough (Sheeba.M.S, Asha.V.V.,2009). 
 C.halicacabum leaf juice cures the ear ache and  Haemorrhoids .Leaves 
and stalks of the plant are used as Diarrhoea and Dysentry .(Raza S et al 
2013).   
PHARMACOGNOSY: 
MACROSCOPY: 
 Leaves are alternate and have axillary tendrils.( Krishna Murti et al.,2010). 
 Leaves are ternate biocomponent and leaflets acuminate at top. The 
leaflets are mostly 3-part and pinnately lobed having narrowed 
stalks.Leaflets are variable in shape ovate or narrowly ovate.Leaf stalk is 
long, ridged, slim and with tiny stipules at the base.(Raza s et al .,2013). 
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 Texture: Sparsely pubsecent .leaves alternated and compound, deltoids, 
2-ternate, serrate, very acute appex and narrow base. This plant leaf has 
bitter taste (Patil et al.,2010).              
 MICROSCOPY: 
 C.halicacabum dorsiventral leaf. Tissues are present in the midrib and 
lamina (shows upper epidermis).Xylem towards the dorssal surface phloem 
towards the ventral surface. (Patil et al.,2010). 
 hypostomatic and anomocytic stomata, has non-glandular and glandular 
trichomes, and also secretory cells present in mesophyll sponge cells in the 
C.halicacabum leaves. Cuticle on the epidermal of leaf surface of the 
C.halicacabum. .( Mohd. norfazil.G et al.,2017,Patil et al.,2010). 
MIDRIB: 
 Outline: adaxial: protruding structure form into hump; abaxial 
side:U-shaped. closed system; consisting of adaxial and abaxial vascular 
bundles. Sclerenchyma cells: few layers of sclerenchyma cells present at 
the outer layer of phloem tissue. Parenchyma cells: parenchyma cells at 
the medullary área have are larger than other parenchyma cells found in 
the midrib. Collenchyma cells: layers of collenchyma cells present 
underneath epidermis at the adaxial side. Cells inclusión: druses, secretory 
cells present found in medullary and parenchyma cortex area. Trichome: 
simple unicellular, mainly at the abaxial side.( Mohd. norfazil.G et al.,2017).   
LEAF LAMINA:  
 Cuticular layer: relatively thick. Adaxial epidermis: single layer with 
height:width ratio – 1:2. Abaxial epidermis: single layer with height:width 
ratio – 1:1. Chlorenchyma cells: mesophyll palisade: single layer filling ½ 
 
CHAPTER II                                            LITERATURE REVIEW 
 
DEPARTMENT OF PHARMACOGNOSY,MMC,MADURAI Page 36 
 
part of the height of leaf lamina. Spongy mesophyll: 4-5 layers of spongy 
mesophyll. Vascular bundles: simple vascular bundles. Parenchyma cells: 
single layer encircles each vascular bundle. Trichome: simple, 
unicellular,mainly present on adaxial leaf surface, papillae (dome-shaped) 
densely covering the adaxial leaf surface.( Mohd. norfazil.G et al.,2017, 
Patil et al., 2010). 
  PETIOLE: 
 Outline: rounded, 45º recurved downwards to the abaxial side.Adaxial side: 
presence of protruding structure (wings) on the left and right of adaxial 
side; abaxial side: U-shaped. Epidermal cells: ratio height: width (3:1). Main 
vascular tissue system – closed system, consists of one continous vascular 
tissue in “0” shape. ( Mohd. norfazil.G et al.,2017). 
POWDER MICROSCOPY: 
 The characterstic of powder leaf shown covering unicellular trichomes, 
spiral thickening, stomata and fibres.(Patil et al.,2010). 
 The powder of leaves of C.halicacabum shows acicular crystal,rosette 
crystals of calcium oxalate. Acicular crystals are needle like, slender long 
pointed at the end clusters. fragmented oil cells are also present.Glandular 
and watry unicellular trichomes are present. paranchyma cells  contain 
mucilage and sclerenchyma also present.(Suhas.S.N,Vidya vilas.,2014).           
PHYTOCHEMISTRY: 
 The C.halicacabum leaves contain total phenolic contents 38.04 ± 0.50, 
total flavonoid contents 1.05 ± 0.01 and total tannin content 4.99 ±. 
0.33.(Senthilkumar.S and Vijayakumari.K.,2012). 
 C.halicacabum ethanolic extract of leaves of LC/MS/MS indicate presence 
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of Anti inflammatory compounds Luteolin-7-o-glucronide,Apigenin 7-0- 
glucronide and Chrysoeriol.(Jeyadevi R et al.,2013). 
 Flavonoid, Terpenoids and cardiac glylosides were predominantly found in 
the Acetone, Chloroform,Diethyl ether  solvent extracts of leaf of  
C.halicacabum.( Annadurai A,et al.,2013). 
 It was reported steroids present in dried leaf powder of C.halicacabum 
.(Suhas.S.N,Vidya vilas.,2014).           
 C.halicacabum leaves contain considerable amounts of saponins , 
alkaloids, (+)-pinitol, apigenium, luteolin. minerals such as Ca (1.30%), K 
(4.01%), Mg (0.43%), P (0.83%), Organic-N (5.19%), Total-N (7.16%), and 
C (48.1%) are present. The major cyano lipid (49%) is a diester having two fatty 
acid moieties esterfied with 1-cyano-2- hydroxymethyl-prop-2ene-l-ol followed 
by a diester derived from 1-cyano- 2-hydroxymethyl-prop-2-ene-3-ol (6%). other 
chief components of the  oil include oleic acid (22%), arachidic acid (10%), 
linolenic acid (8%), palmitic acid (3%) and stearic acid (2%) including small 
proportions (1- 2%) of a low-molecular weight acid, and several C22 acids.( 
Prabakaran.S, Pugazhendy.K and Revathi.A.,2014). 
PHARMACOLOGY: 
Acute toxicity studies 
Acute toxicity studies were carried out on rats for EECH at doses of 50, 
100, 500, 1000 and 2000 mg/kg body weight. The acute toxicity of extract showed 
no mortality and morbidity even under high dose levels (2000mg/k b.w.) indicating 
high margin of safety of the plant extract. (Vijayakumari K, Senthilkumar S., 2017). 
 Leaves of this plant rubefacient and used in the treatment of 
rheumatism.(Malaviya S et al.,2009). 
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 In vitro studies reported ethanolic crude extract of the leaf of C. 
halicacabum inhibit TNF-α and nitric oxide in human peripheral blood 
mononuclear cells (Swaminathan.P, Saleena.L et al.,2017). 
ANTIMICROBIAL ACTIVITY: 
 The leaf and stem extracts of C.halicacabum were reported for their 
antimicrobial activity against S. aureus, B.Subtilis, C. freundii, E. coli, P. 
aeroginosa, S typhi, K. pneumonia.(Viji.M,Murugesan.S.,2010). 
 The antimicrobial activity of the leaf extract was assayed by Cup plate or 
cylinder plate method against 3 bacterial species S. aureus, B. substilis and 
E.coli.(  Deepan T, Alekhya V, Saravanakumar P and  Dhanaraju M D., 
2012). 
ANTI-ARTHRITIC ACTIVITY: 
 The ethanolic extract of leaves give Anti- arthritic effect.The leaf extract 
treated in Diabetic rats reduce the hyperglycemic and reduce the 
Glycoprotines in plasma,liver and kidney.It increases the serum albumin 
phosphate, creatinine, blood urea nitrogen. In rats methanolic extract 
improved result than petroleum ether extract.(Patil et al.,2010).  
ANTI DIABETIC ACTIVITY: 
 This plant leaf possesses several flavonoids such as apigenin, pinitol and 
luteolin which are reported as the antidiabetic activity.(Veeramani C et 
al.,2012.). 
 The C.halicacabum leaf of methanol extract at a concentration of 50g plant 
was found to be more potent than other extracts with the lowest mean 
glucose concentration of 201±1.69 mg/dl at the end of 27 hrs. A Decoction 
of Cardiospermum halicacabum leaves was screened for hypoglycaemic 
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activity on alloxan-induced diabetic rats.. (Stalin.C, Vivekanandan.K and 
Bhavya.E.,2013). 
 The antihyperglycemic effect of cardiospermum halicacabum leaf extract 
may be attributed to activation of glucose uptake, inhibition of intestinal 
glucose transporter and decreasing the expression of genes that control 
gluconeogenesis.(Veeramani.C et al., 2015). 
 CHE is potent inhibitor of cardiac dysfunction and improve the membrane 
fluidity on STZ-induced diabetic rats. antihyperglycemic, antioxidant and 
antihyperlipidemic properties of CHE  could be helpful to maintain the 
levels of membrane-bound ATPases in STZ-induced diabetic rats showing 
the membrane stabilizing property of extract. (Veeramani.C et al., 2015). 
CNS ACTIVITY: 
 The 95% ethanol extract of the leaves has been reported to produce 
central nervous system depression. (Rupeshkumar .M, Kavitha.K, 
Basu.S.K.,2012). 
RADICAL SCAVENGING ACTIVITY: 
 It was reported The ethanolic leaf extract of C.halicacabum contain phenol 
and flavones it has free radical scavenging activity.(Senthilkumar.S and 
Vijayakumari.K et al.,2012). 
ANTIHYPERLIPIDIMIC ACTIVITY: 
 Elevated level of plasma total cholesterol, phospholipids, triglycerides, and 
free fatty acids has been observed in the STZ-induced diabetic rats but 
treatment with the plant brings them to their normal level. It also elevated 
plasma low-density lipoprotein (LDL-C) and very low-density lipoprotein 
(VLDL-C) and lowered high-density lipoprotein (HDL-C). Hence, it has been 
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shown that in these rats the plant play antioxidant and hypolipidemic 
activity, and the existence of flavonoids, like apigenin and luteolin are 
responsible for this activity (Veeramani et al., 2010). 
 Cardiospermum halicacabum aqueous leaf extract (0.01-0.625 mg/mL) 
showed significant inhibition on LDL glycation in a dose-dependent 
manner. (Stalin.C, Vivekanandan.K and Bhavya.E.,2013). 
ANTI-INFLAMMATORY AND ANTIPYRETIC ACTIVITY: 
 Ethanolic extract of C.halicacabum leaves have the Anti-inflammatory 
activity against carragenan induced paw- edema method.This extract of 
leaves are also useful to the Antipyretic activity against yeast in 
rats.(Jeyadevi R et al., 2013). 
SPERM MOTILITY: 
 Aqueous leaf extract (ALE) of Cardiospermum halicacabum for 30 days 
was reported produced a significant dose dependent increase in the sperm 
counts and sperm motility in both caput and cauda regions.(Dinithi.L et al., 
2015). 
ANTIULCER ACTIVITY: 
  The leaves of C. halicacabum possess significant anti ulcer activity may 
probably due to the presence of interesting bioactive compounds like 
flavonoids, tannins, phenols, saponins and caffeic acid.( Vijayakumari K 
and Senthilkumar S.,2017)  
ADULTICIDAL ACTIVITY: 
 Leaf extract have extraordinary Adulticidal role.(Raza S et al., 2013). 
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ANTIOXIDANT ACTIVITY: 
 The ethanolic extract of C.halicacabum leaves (EECH) has  Antioxidant 
and Antirheumatic activity in wristar rat.Orally dose 250 and 500 mg.Daily 
for 20 days.Reference –Diclofenac.( Kumaran and Karunakaran, 2006).  
 The combined petroleum ether extract of Cardiospermum halicacabum L. 
and Delonix elata L. leaves (CPCD) possess antioxidant activity. 
(Ravichandran.S and Panneerselvam.IP.,2013).( Scartezzini P, Speroni E., 
2000). 
ANXIOLYTIC AND MEMORY ENHANCING ACTIVITY: 
 The methanolic extract of Cardiospermum halicacabum leaves have 
anxiolytic activity and memory enhancing activity, that was reported. 
(Mahmood.R et al.,2015). 
STEM: 
PHARMACOGNOSY: 
 Stem is 5-grooved,slim and hairless to sparingly hairy.(Raza S et al., 
2O13). 
PHYTOCHEMISTRY: 
 Petroleum ether extract of stem of this plant was reported presence of 
carbohydrates, steroid, terpenoid and trace amount of alkaloid and 
glycosides. Chloroform extract of this plant was repotred presence of 
carbohydrates, steroid, terpenoid, glycosides, alkaloid, phenols and 
tannins. Ethyle acetate extract of this plant has carbohydrate, steroid, 
terpenoids, phenols, tannins, proteins, amino acids, glycosides, flavanoids, 
and alkaloids and methanolic extract of this plant has carbohydrates, amino 
acids, phenols, tannins,alkaloids,glycosides andaqoues extract of this plant 
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was reported carbohydrates, flavanoids, amino acids, proteins, steroids, 
terpenoids, phenols, tannins, glycosides, alkaloids.(Ara.A,Srinivasa reddy. 
K,C.S Reddy., 2009). 
 Tannins, Flavonoid, Terpenoids and cardiac glylosides and anthrquinonus 
were predominantly found in Acetone, chloroform, diethyle ether extracts of 
the stem.( Annadurai A et al.,2013) 
PHARMACOLOGY: 
ANTIMICROBIAL ACTIVITY: 
 Acetone extract of stem of this plant active against micrococcus luteus(35 
mm),proteus vulgaris and staphylococcus areus (32 mm).(Selvarani .S et 
al.,2015). 
FLOWER: 
 PHARMACOGNOSY: 
 Flowers are white in colour and are small.These are unisexual,obliquely 
zygomorphic having stright pedicel.(Raza S et al., 2013). 
FRUITS: 
  PHARMACOGNOSY: 
 Fruits are membranous, depressed pyriform caring branched at the 
angles.It is a spherical caring, inflate 3 lobed and 3- celled.(Jeyadevi R et 
al., 2013).( Krishna Murti et al.,2010). 
SEEDS: 
ETHNOMEDICAL USE: 
 Seeds are used as a tonic for fever and as a diaphoretic.(Dhayabaran D et 
al.,2012). 
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 The seeds of C.halicacabum is used as oral pain relievers or applied to 
aching joints as a paste.(Krishna murthy naik.V,et al.,2014). 
PHARMACOGNOSY: 
 Seeds are black in colour.It has large white heart formed aril.(Raza S et al., 
2013). 
 The C.halicacabum seed  is round, black and lined, roughly 1/3 of the 
surface, with a white heart shaped “finely porous,chordate spot at the 
micropyle” . The strength of the seed coat is hypothesized to extend the 
viability of the seed over time.( Matthew Anthony Dempsey, B.A.,2011). 
PHYTOCHEMISTRY: 
 seeds of this plant contains 33% of fatty acids, and of these fatty acids, 
about 55% are cyano lipids. Cardiospermum halicacabum seed protein 
content (35.9% by dry weight) and amino acids in g/100g protein (Asp 
8.3%, Thr 4.1%, Ser 6.0%, Glu 15.9%, Pro 3.2%, Gly 9.2%, Ala 6.6%, 
1/2Cys 1.1%, Val 6.3%, Met 0.9%, Ile 3.9%, Leu 5.7%, Tyr 1.8%, Phe 
3.8%, His 2.7%, Lys 3.9%, Arg 5.1%).(Subramanyam R et al., 2007).  
 seed coat contains Tannins, Flavonoids and Terpenioids were 
predominantly found in Acetone,Diethyle ether,chloroform extracts of 
C.halicacabum.( Annadurai.A,Elangovan.V, Velmurugan.S.,2013) 
PHARMACOLOGY: 
 Seed oil was reported to posses anticancer activity. 
 seeds are used as a tonic for fevers and as a diaphoretic.( (Sheeba.M.S, 
Asha.V.V.,2009). 
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ROOT: 
ETHANOMEDICAL USE: 
 Root of this plant helpful for nervous disease and it also used as emetic, 
laxative.(Dhayabaran D et al .,2012). 
 The root is mucilaginous and considered emetic, laxative and 
antirheumatic. (Sheeba.M.S, Asha.V.V.,2009).  
PHYTOCHEMISTRY:  
 Alcoholic extract of root of this plant contains fixed 
oils,fats,protiens,flavanoids,phenolics,tannins,carbohydrates,saponins,phyt
osterols and triterpenoids.(Dhayabaran D et al.,2012). 
PHARMACOLOGY: 
ANTIANXIETY ACTIVITY: 
 In a study conducted in mice using alcoholic and aqueous root extracts of 
cardispermum halicacabum reported to be helpful in investigating the anti 
anxiety effects.(Malaviya.S et al.,2009). 
ANTIEPILEPTIC ACTIVITY: 
 Alcoholic root extract of C.halicacabum L used in epilepsy.It was reported 
in swiss albino mice dose( 30,100 and 300 mg/kg).Root of this plant also 
used as anxiety.(Dhayabaran D et al.,2012). 
PINITOL: 
 Pinitol is a very common cyclitol present in many leguminous plants and it 
is the mono methyl ether of d – inositol and commercially very important 
anti-diabetic molecule proven to have insulinomimetic action and is 
non-toxic with no side effects. (Shubashini K.et al.,2011). 
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 Pinitol is a completely non-toxic. pinitol has been reported hypoglycemic 
action and anti-hyperlipidemic effect well established. Clinical trials on the 
effect of pinitol on glycemic control and lowering cardiovascular risk factors 
in patients with type II diabetes mellitus have been proved. Pinitol is 
reported safe and nontoxic as an anti-diabetic agent even at high levels.( 
Pavithra et al.,2017). 
 The name pinitol is derived from “pine,” as it was first isolated from a pine 
tree.(International Journal of Basic & Clinical Pharmacology.,2015.) 
 The D-pinitol also lowered significantly (p ¡ 0.05) LDL andVLDL cholesterol 
levels and increased significantly (p ¡ 0.05) HDL cholesterol levels in the 
serum of diabetic rats. Thus, the present study clearly showed the 
antihyperlipidemic effect of D-pinitol in STZ-induced type II diabetic rats. 
Synonyms:  
-O-Methyl-D-chiro-inositol;  
                   D-(+)-chiro-Inositol;D-Pinitol;  
                   Inzitol;  
                   D-(+)-Pinitol; (+)-Pinitol (Gobato R,et al.,2016). 
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ZEBRAFISH - AN In Vivo MODEL FOR DRUG SCREENING 
Zebrafish (Danio rerio) as a model organism for investigating endocrine 
disruption. Study was carried out on endocrine-disrupting compounds (EDCs) 
which are widespread in the aquatic environment will cause alterations in 
development, physiological homeostasis and health of vertebrate. When the 
morpholino technique is used to knockdown cyp19a1 in the zebrafish embryo, 
translating EDC induced molecular responses into organism toxicity and 
disease was found to be getting more complicated for older life stages. 
(Senger, H 2009). 
Studies has been carried to assess pharmacological effects of drugs on 
the optic nerves, motor neurons, and dopaminergic neurons and performed 
whole mount immunostaining were performed and visualized different neuronal 
cell types in vivo. Showed that compounds that induce neurotoxicity in humans 
caused similar neurotoxicity in zebrafish (Parng, C et al., 2007). 
An in vivo transgenic model of zf was used to screen two known 
antiangiogenic compounds SU4312 and AG1478 in which additionally 
indirubin-3-monoxime was identified which showed that each of the hit 
compounds had dose dependent antiangiogenic activity (Sandbeg, E 2007). 
A novel system has been developed in which zf is amenable to 
transgenic and both forward and reverse genetic strategies that can be used to 
identify or generate zf models of different type of cancer. Ultimately, 
high-throughput modifier screens based on zf cancer models can lead to the 
identification of chemical or gene involved in the suppression or prevention of 
the malignant phenotype (Berghmans, S et al., 2005). 
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 A data on behavioral responses of adult zebrafish to a wide spectrum 
of putative anxiolytic and anxiogenic agents was carried out . Using the novel 
tank test as a sensitive and efficient behavioral assay, zebrafish anxiety-like 
behavior can be bi-directionally modulated by drugs affecting the 
gamma-aminobutyric acid, monoaminergic, cholinergic, glutamatergic and 
opioidergic systems (Stewart, A et al., 2010). 
Work has been carried out to evaluate the teratogenic effect of the 
human antiepileptic drug valproic acid which generates malformation such as 
oedema, brain deformities, a shortened and bent tail and bipartite axiation of 
the posterior trunk on zebrafish larvae (Herrmann, K 1993). 
A survey has taken on the stock of the available zebrafish assays in the 
context of alternative mammalian cell-based assays, and of the validation 
outcomes to date and the survey data indicate that the preferred way forward 
would be a collaborative effort between the pharmaceutical/biotechnology 
industry and the zebrafish contract research companies, alongside expert input 
from academia and regulatory authorities (Redfern, WS et al., 2008).    
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CHAPTER III 
AIM AND OBJECTIVE 
The number of diseases associated with hyperlipidemia is rapidly 
increasing. Current experimental studies of hyperlipidemia often use genetically 
modified  mice,  rabbit  and  hamster  fed  high  fat,  high-cholesterol  diets,  which 
rapidly induce extreme hyperlipidemia and lipid accumulation in the artery wall. In 
addition,  mammalian  hyperlipidemia  models  are  often  time-consuming,  labor 
intensive and expensive. 
Inhibition of dietary lipid is an emerging strategy for the treatment of lipid 
metabolitic  complications  of  cardiovascular  system.  class  of  pharmacological 
agents which commonly used are orlistat and ezetimibe which improve the serum 
lipoprotein profiles of patients those are at high risk of stroke, acute coronary 
syndrome and sudden death, and therefore it can be used as an adjuvant to HMG 
co-reductase inhibitors (statins). 
Cell culture models and in other in vitro systems of drug screening has 
been carried out, but due to lack of organ structures, extrapolation of these results 
to the whole organism is often challenging. Live animal in vivo  model that allows 
a  detailed  analysis  of  lipid  metabolism  would  be  highly  valuable  for  lipid 
metabolism studies and for lipid-lowering drug screening. 
Given  the  prevalence  of  lipid  metabolism  disorders  lead  compound 
identification is desirable and that can be developed into new formulations which 
then inhibit the absorption of lipids via novel mechanisms. Here we report the 
utility of zebrafish for this study. Because of their small size, optical 
DEPARTMENT OF PHARMACOGNOSY ,MMC,MADURAI Page 49 
CHAPTER III AIM AND OBJECTIVE 
transparency of zf larvae which are well suited for chemical library screens 
using morphological assays. Compound efficacy can be rapidly assessed and 
toxicity studies can be performed in vivo which makes it a great advantage in 
chemical screens. This study is aimed primarily at phytochemical and bioactivity of 
EECHL from the leaves of C.halicacabum as potential biological and 
pharmacological resources in the above aspects. 
AIM: 
To study the pharmacognostical, preliminary phytochemical and in 
vivo  effect  on  the  hyperlipidemic  zebrafish  larvae and  cardiovascular 
system of the ethanolic extract of the leaves of Cardiospermum 
halicacabum L. family Sapinadaceae. 
OBJECTIVE: 
The objective of the study was divided into 3 parts. 
Part 1: Pharmacognostic study:- 
Collection and authentification of plant. 
Macroscopy of the leaf 
Microscopy :- 
1.Anatomical studies. 
2.Microscopic schedules. 
3.Scanning Electron Microscopic study (SEM). 
4.Powder microscopy of the leaf 
Physico-chemical parameters:- 
1.Ash values. 
2.Loss on drying. 
3.Extractive values. 
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Part 2: Preliminary phytochemical screening:- 
Qualitative analysis of the leaves for the presence of various 
phytoconstituents. 
Determination of trace elements present in the leaves by Energy Dispersive 
Spectrum  analysis  (EDS)  preparation  of  Ethanolic  extract  of  the  leaves  of 
C.halicacabum (EECH) Determination of flavonoid content, total phenolic content 
of the leaves of C.halicacabum. HPTLC profile of the EECHL to identify and 
quantify pinitol. 
Part 3: Pharmacological screening:- 
The  3R’s  ethical  principle  (Reduction,  Refinement,  Replacement)  was 
implemented that help to minimize harms to vertebrate animals used in science. 
Collection of zebra fish (zf) larvae. 
To study the preliminary toxicological studies of the EECHL on the early 
development of zf 
1.Whole embryo culture toxicity study 
2.Larval toxicity study 
Efficacy assessment of EECHL on in vivo hyperlipidemic zf larvae model 
To determine the effect EECHL on the CVS (cardiac morphology, blood 
circulation) of zf larvae. 
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CHAPTER IV MATERIALS AND METHODS 
4.1. PLANT COLLECTION AND AUTHENTIFICATION: 
Leaves of the plant Cardiospermum halicacabum L. selected for our study 
was collected from Alampattu, Sivagangai District, Tamil Nadu, India during the 
month of June 2017 and was authenticated by Dr. D. Stephen, Department of 
Botany, American college, Madurai. 
LEAF DRYING AND PULVERIZING: 
The leaves were collected and shade dried. It was powdered in a mixer. The 
powder was sieved in a No.60 sieve and kept in a well closed container in a dry 
place. 
4.2. PHARMACOGNOSTICAL STUDIES: 
Morphological and micro morphological examination and characterization of 
medicinal plants have always been accorded due credentials in the 
pharmacognostical studies. Botanical identity of the plants is an essential 
prerequisite for undertaking the analysis of medicinal properties of any plant. A 
researcher  may  succeed  in  getting  a  new  compound  or  may  find  many  useful 
pharmacological active properties in the plant. If the botanical identity of the plant 
happens to be dubious or erratic, the entire work on the plant becomes invalid. Thus 
it is needless to stress the botanical identity of the crude drug is the threshold in the 
processes of pharmacological investigations. The researchers should be equipped 
with all possible diagnostic parameters of the plant on which the researchers plan to 
work. 
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4.2.1. MORPHOLOGICAL STUDIES OF C.halicacabum L: 
Aerial part, leaf and petiole, flower, fruits and root were studied individually for 
its morphological characters by organoleptic test. 
4.2.2. MICROSCOPICAL STUDIES ON THE LEAF OF C.halicacabum: 
COLLECTION OF SPECIMEN: 
Care was taken to select healthy plants and for normal organs. Leaf, Petiole 
specimens were collected from a healthy plant by making a cut with petioles.The 
materials  were  cut  into  pieces  and  immediately  immersed  in  fixative  fluid  FAA 
(Formalin – 5ml + Acetic acid – 5ml +70% Ethyl alcohol – 90ml). 
DEHYDRATION: 
After 24 hours of fixing , the specimens were dehydrated with graded series of 
ethyl alcohol and tertiary-butyl alcohol (Sass, JE 1940). The specimen is kept is in 
each  grade  of  the  fluid  for  about  6  hrs.Every  time  the  fluid  is  decanted  and 
immediately the specimen were flooded with next grade of fluid. 
INFILTRATION WITH PARAFFIN WAX: 
After  dehydration,  the  shavings  of  paraffin  wax  were  added  to  the  vial 
containing the plant material with pure TBA. The paraffin shavings are added every 
30mts at about 40-45ºC four or five times. Then the vials were filled with wax without 
damaging the tissues. The vial filled with wax is kept open in warm condition to 
evaporate all TBA, leaving the specimen in pure molten wax. The specimen filled 
with pure molten wax for 2 or 3 times by decanting the old wax every time. 
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CASTING TO MOLD: 
A boat made out of chart board, by folding the margin, is used to prepare a 
mold of wax containing specimens. The paraffin along with the leaf and petiole 
specimen was poured into the boat. With the help of heated needles, the specimen 
were arranged in parallel rows with enough space in between the specimens. The 
block was then immersed in chilled water and allowed to cool for few hours. 
SECTIONING: 
The paraffin embedded specimens were sectioned with the help of microtome. 
The  thickness  of  the  sections  was  10-12μm.  Dewaxing  of  the  sections  was  by 
customary procedure. The sections were stained with Toluidine blue as per the 
method published by O’Brien, TP et al., (1964). 
Since  toluidine  blue  is  a  poly  chromatic  strain,  the  straining  results  were 
remarkably good and some cytochemical reactions were also obtained. The dye 
rendered pink colour to the cellulose walls, blue to the lignified cells, dark green to 
suberin,  violet  to  the  mucilage,  blue  to  the  protein  bodies  etc.  Where  ever 
necessary sections were also stained with safranin and fast-green and potassium 
iodide (for starch ). For studying the stomatal morphology, venation patttern and 
trichome distribution, paradermal sections (sections taken parallel to the surface of 
leaf as well as clearing of leaf with 5% sodium hydroxide or epidermal peeling by 
partial  maceration  employing  Jeffrey’s  maceration  fluid  were  prepared.  Glycerin 
mounted  temporary  preparations  were  made  for  macerated/cleared  materials. 
Powdered  materials  of  differentparts  were  cleared  with  sodium  hydroxide  and 
mounted in glycerin medium after staining. Different cell components were studied 
and measured. (Sass, JE 1940). 
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PHOTOMICROGRAPHS: 
Microscopic  descriptions  of  tissues  are  supplemented  with  micrographs 
wherever necessary. Photographs of different magnifications were taken.with Nikon 
labphot 2 Microscopic unit. For normal observations bright field was used. For the 
study of crystals, starch grains and lignified cells, polarized light were employed. 
Since these structures have birefringent property, under polarized light they appear 
bright against dark background. Magnifigations of the figures are indicated by the 
scalebars. (Johansan, DA, 1940, Purvis, MJ et al., 1966). 
4.2.3. MICROSCOPICAL STUDY OF LEAF USING SCANNING 
ELECTRON MICROSCOPE: 
Movement of beam of foccussed electrons across an object forms a 3D image 
on a cathode - ray tube in a Scanning Eectron Microscope and it reads both the 
electrons scattered by the object and the secondary electrons produced by it. The 
electromagnetic lenses are used in SEM and focussing is done by the current. On 
photographic plate of screen the image is projected which gives comprehensive, 
quasi 3-D representation of the objects gives the ultra structure of plant cells. In 
addition , shows the unsuspected details and any undescribed characters. In other 
words the micrograph from SEM, shows the best possible structural details of the 
specimens. (Robards, 1970). 
USAGE: 
SEM info was handled as conventional character (or) character complexes as 
“pure” information without being broken down (or) interpreted as individual character 
using computer processing. The SEM information can be used some what at the 
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superficial level just described to assist in solving taxonomic problem by confirming, 
changing (or) other grounds. It is also used often as diagnostic feature to avoid 
misleading  by  over  simplified  descriptions  and  one  may  find  new  kinds  of 
microstructures not previously recognised and apprently simple structures may be 
extremely complex. Remarkably, poor conventional descriptions enabling taxonomic 
process of reducing a complex pattern to a few simple characters (Heywood, VH, 
1971). 
SEM plays a vital role when a specimen need to be satisfactorily defined in 
terms of characters. For most biological materials, maximum information is obtained 
by employing light and electron microscopy jointly and an attempt was made by 
applying SEM to the leaf of C.halicacabum , to pinpoint the positions of specific 
characters with in the cell, which can be easily seen in final image. 
SEM SAMPLE PREPARATION: 
Sample for SEM analysis were mounted on the specimen stub using carbon 
adhesive sheet. Small sample were mounted with I sq. cm glass slide and kept in 
carbon adhesive sheet.. Samples were coated with gold to a thickness of 100 AO 
using  hitachi  vacuum  evaporator.  Coated  sample  were  analysed  in  a  Hitachi 
Scanning electron Microscope 3000 H model. 
4.2.4. POWDER MICROSCOPY: 
MACERATION TECHNIQUE: 
Maceration  is  the  process  of  separation  of  individual  cells  by  selectively 
dissolving the pectic middle lamella between the cells. The middle lamella binds the 
cells with each other forming different tissues. The middle lamella is dissolved by 
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employing a chemical that dissolves the lamella to free the cells to obtain their three 
dimensional view. 
MACERATION FLUID: 
Jaffrey’s  maceration  fluid  is  one  that  is  commonly  used  for  maceration 
(Johansan, DA, 1940). The fluid consists of equal volumes of 5% chromic acid and 
5% nitric acid. The plant material is cut into small pieces and immersed in the 
maceration fluid. The fluid with the materials is kept at 55ºC for 3-5 hrs. Then the 
material is washed thoroughly with water and placed on a glass slide in a drop of 
Safranin (0.5%) for 15-20 min. The stain is drained carefully and mounted with a drop 
of dilute glycerine. The cells are spread well with a needle and the material is 
covered with cover slip. The slide so prepared is examined under the microscope to 
study different components of the macerate. 
4.2.5 MICROSCOPIC SCHEDULES: (Wallis, TE. 1953, Wallis, TE, 
1965, Iyengar, MA, 1994, Anonymous, 2001) 
The vein islet number, vein terminal number, stomatal number and stomatal 
index were determined on fresh leaves using standard procedures. 
A. VEIN ISLET NUMBER AND VEIN TERMINATION NUMBER: 
The term vein islet in used to denote the minute area of photosynthetic tissue 
encircled by the ultimate divisions of the conducting strands. The number of vein 
islets per sq.mm. Area is called vein islet number. 
Vein terminal number may be defined as the number of vein terminals present 
in one sq., mm. area of the photosynthetic tissue. 
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B. DETERMINATION OF VEIN ISLET NUMBER AND VEIN 
TERMINATION NUMBER: 
Small square portion from the lamina region of the leaf was cleared in chloral 
hydrate, stained and mounted on a slide. A camera Lucida is set up and by means of 
a stage micro meter the paper is divided into squares of 1mm2  using a 16mm 
objective. The stage micro meter is then replaced by the cleared preparation and the 
veins are raced in four continuous squares, either in a square 2mm x 2mm (or) 
rectangle 1mm x 4 mm. 
When counting, it is convenient to number each vein-islet on the tracing. Each 
numbered  area  must  be  completely  enclosed  by  veins,  and  those  which  are 
incomplete are excluded from the count if cut by the top and left-hand sides of the 
square (or) rectangle but included if cut by the other two sides. Ten readings for vein 
islet and vein termination number were recorded. 
C. STOMATAL INDEX: 
It is the percentage, which the numbers of stomata from the total number of 
epidermal cells, each stoma being counted as one cell. 
I. Stomatal index = S/S+E x 100 
Where, S = Number of stomata per unit area. 
E = Number of epidermal cells in the same unit area. 
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D. DETERMINATION OF STOMATAL INDEX: 
The  procedure  adopted  in  the  determinations  of  stomatal  number  was 
observed  under  high  power  (45  X).The  epidermal  cells  and  the  stomata  were 
counted. From these values the stomatal index was calculated using the above 
formula. 
4.2.6 PHYSICOCHEMICAL PARAMETERS: (Anonymous, 1996, 1998, 
2001) 
DETERMINATION OF ASH VALUES: 
ASH VALUE: 
The ash values were determined by using air dried powder of the leaf as per 
the official method. 
TOTAL ASH: 
Two grams of the air dried leaf powder was accurately weighed in a silica 
crucible separately. The powder was scattered into a fine even layer on the bottom of 
the crucible and incinerated by gradually increasing the temperature not exceeding 
450oc, until free from carbon. Then it was cooled and weighed for constant weight. 
The percentage of ash with reference to the air dried powder was calculated. 
WATER SOLUBLE ASH: 
The ash obtained from the total ash procedure was boiled with 25ml of water 
for 5 minutes and the insoluble matter was collected on an ash less filter paper and 
washed with hot water. Then it was ignited for 15 minutes at a temperature not 
exceeding 450oc. The weight of the insoluble matter was subtracted from the weight 
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of the total ash. The difference in weight represents the water soluble ash. The 
percentage  of  water  soluble  ash  was  calculated  with  reference  to  the  air  dried 
powder. 
ACID INSOLUBLE ASH: 
The ash obtained from the total ash was boiled for five minutes with 25ml of 
dilute hydrochloric acid. The insoluble matter was collected in a tarred sintered glass 
crucible.  The  residue  was  washed  with  hot  water,  dried  and  weighed.  The 
percentage of acid insoluble ash with reference to the air dried drug was calculated. 
DETERMINATION OF LOSS ON DRYING 
For the determination of loss on drying, the method described by Wallis was 
followed. One gram of dried powdered leaf was accurately weighed in a tarred Petri 
dish,  previously  dried  under  the  conditions  specified  in  IP’96.  The  powder  was 
distributed as evenly as practicable, by gentle sidewise shaking. The dish was dried 
in an oven at 100 – 105°C for 1 hour. It was cooled in desiccators and again weighed. 
The loss on drying was calculated with reference to the amount of the dried powder 
taken. 
EXTRACTIVE VALUES 
 PETROLEUM ETHER SOLUBLE EXTRACTIVE VALUE 
Five gram of the coarsely powder was macerated separately with 100ml of 
petroleum ether in a closed flask for 24 hrs. It was frequently shaken for the first 6 
hours and allowed to stand for 18 hours. Thereafter it was filtered rapidly taking 
precaution against loss of petroleum ether. 25ml of the filtrate was evaporated to 
dryness in a tarred flat bottomed shallow dish, dried at 105oC and weighed. The 
DEPARTMENT OF PHARMACOGNOSY MMC,MADURAI Page 61 
CHAPTER IV MATERIALS AND METHODS 
percentage  of  the  petroleum  ether  soluble  extractive  value  was  calculated  with 
reference to the air dried powder. 
 ETHANOL SOLUBLE EXTRACTIVE VALUE 
Five gram of the coarsely powder was macerated with 100ml of ethanol in a 
closed flask for 24 hrs. It was frequently shaken for the first 6 hours and allowed to 
stand for 18 hours. Thereafter it was filtered rapidly taking precaution against loss of 
ethanol. 25ml of the filtrate was evaporated to dryness in a tarred flat bottomed 
shallow dish, dried at 105oC and weighed. The percentage of the ethanol soluble 
extractive value was calculated with reference to the air dried powder. 
 WATER SOLUBLE EXTRACTIVE VALUE: 
Five gram of the coarsely powder was macerated separately with 100ml of 
chloroform water in a closed flask for 24 hrs. It was frequently shaken for the first 6 
hours and allowed to stand for 18 hours. Thereafter it was filtered rapidly taking 
precaution against loss of chloroform water. 25ml of the filtrate was evaporated to 
dryness in a tarred flat bottomed shallow dish, dried at 105oC and weighed. The 
percentage of the chloroform water soluble extractive value was calculated with 
reference to the air dried powder. 
4.3 PHYTOCHEMICAL STUDIES: 
(Anonymous, 1998, Chaudhri, RD, 1999, Kokate, CK, 2005, Agarwal, SS 
2007, Horbone, JB, 1973). 
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4.3.1 PRELIMINARY PHYTOCHEMICAL SCREENING: 
TEST FOR ALKALOIDS: 
VARIOUS PROCEDURES TO LIBERATE ALKALOIDS: 
Powdered drug was mixed thoroughly with 1ml of 10% ammonia solution and 
then extracted for 10 minutes with 5 ml methanol, under reflux. The filtrate was 
then concentrated. 
Powdered drug was mixed thoroughly with 1ml of 10% sodium carbonate 
solution and then extracted for 10 minutes with 5ml methanol, under reflux. 
The filtrate was then concentrated. 
Powdered drug was ground in a mortar for about 1 minute with 2ml of 10% 
ammonia solution and then thoroughly mixed with 7 gram basic Aluminium 
oxide. The mixture was then loosely packed into a glass column and 10ml 
chloroform was added, eluted, dried and methanol was added. 
Powdered drug was shaken for 15 minutes with 15ml of 0.1 N sulphuric acid 
and then filtered. The filter was washed with 0.1 N sulphuric acid to a volume 
of 20ml filtrate; 1ml concentrated ammonia was then added. The mixture was 
then shaken with two portions of 10ml diethyl ether. The ether was dried over 
anhydrous sodium 
Sulphate, filtered and evaporated to dryness and the resulting residue was 
dissolved in methanol. 
Powdered drug was mixed with one gram of calcium hydroxide and 5ml of 
water, made into a smooth paste and set aside for 5 minutes. It was then 
evaporated to dryness in a porcelain dish on a water bath. 20ml of 90% 
alcohol was added, mixed well and then refluxed for half an hour on a water 
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bath.  It  was  then  filtered  and  the  alcohol  was  evaporated.  To  that  dilute 
sulphuric acid was added. 
 The  above  made  extracts  were  tested  with  various  alkaloid  reagents  as 
follows. 
1. MAYER’S REAGENT 
2. DRAGENDORFF’S REAGENT 
3. HAGER’S REAGENT 
4. WAGNER’S REAGENT 
TEST FOR PURINE GROUP (Murexide Test) 
 The residue obtained after the evaporation of chloroform was treated with 1ml 
of hydrochloric acid in a porclain dish and 0.1g of potassium chlorate was 
added  and  evaporated  to  dryness  on  water  bath.  Then  the  residue  was 
exposed to the vapours of dilute ammonia solution. 
TEST FOR CARBOHYDRATES: 
MOLISCH’S TEST: 
 The aqueous extract of the powdered material was treated with alcoholic 
solution of α- naphthol in the presence of sulphuric acid. 
FEHLING’S TEST: 
 The aqueous extract of the powdered material was treated with Fehling’s I and 
II solution and heated on a boiling water bath. 
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BENEDICT’S TEST: 
 The  aqueous  extract  of  the  powdered  drug  was  treated  with  Benedict’s 
reagent and heated over a water bath. 
TEST FOR GLYCOSIDES: 
GENERAL TEST: 
 TEST A: 
200 mg of the powdered drug was extracted with 5ml of dilute sulphuric acid 
by warming on a water bath, filtered and neutralized with 5% sodium hydroxide 
solution. Then 0.1ml of Fehling’s solution I and II were added, until it becomes 
alkaline and heated on a water bath for 2 minutes. 
 TEST B: 
200g  of  the  powdered  drug  was  extracted  with  5ml  of  water  instead  of 
sulphuric acid. Boiled and equal amount of water was added instead of sodium 
hydroxide solution. Then 0.1ml of Fehling’s solution I and IIwere added, until it 
becomes alkaline and heated on a water bath for 2 minutes. 
ANTHRAQUINONES: 
 BORNTRAGER’S TEST: 
The powdered leaf was boiled with dilute sulphuric acid, filtered and to the 
filtrate benzene was added and shaken well. The inorganic layer was separated and 
ammonia solution was added slowly. 
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 MODIFIED BORNTRAGER’S TEST: 
About 0.1gram of the powdered leaf was boiled for two minutes with dilute 
hydrochloric acid and few drops of ferric chloride solution was added, filtered while 
hot and cooled. The filtrate was then extracted with benzene and the benzene layer 
was separated. Equal volume of dilute ammonia solution was added to the benzene 
extract and shaken well. 
TEST FOR CYANOGENETIC GLYCOSIDES: 
Small quantity of the powdered leaf was placed in a stoppered conical flask 
with just sufficient water to cover it. A sodium picrate paper strip was inserted through 
the stopper so that it was suspended in the flask and it was set aside for 2 hours in a 
warm place. 
TEST FOR CARDIAC GLYCOSIDES: 
 KELLER KILLIANI’S TEST: 
About 1gram of the powdered leaf was boiled with 10ml of 70% alcohol for 
two minutes, cooled and filtered. To the filtrate 10ml of water and 5 drops of 
solution  of  lead  sub  acetate  were  added  and  filtered.  The  filtrate  was  then 
extracted with chloroform and the chloroform layer was separated and evaporated 
to dryness. The residue was dissolved in 3ml of glacial acetic acid containing a 
trace of ferric chloride. To this 3ml of concentrated sulphuric acid was added 
along the sides of the test tube carefully. 
 RAYMOND TEST: 
To the alcoholic extract of the leaf, hot methanolic alkali was added. 
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 LEGAL’S TEST: 
To the alcoholic extract of the powdered drug, pyridine and alkaline sodium 
nitro prusside solution were added. 
TEST FOR PHYTOSTEROLS: 
The powdered leaf was first extracted with petroleum ether and evaporated. 
The residue obtained was dissolved in chloroform and tested for sterols. 
 SALKOWSKI TEST: 
Few drops of concentrated sulphuric acid were added to the above solution, 
shaken well and set aside. 
LIBERMANN – BURCHARD’S TEST: 
 To the chloroform solution few drops of acetic anhydride was added and 
mixed well. 1ml of concentrated sulphuric acid was added through the sides of 
the test tube and set aside for a while. 
TEST FOR SAPONINS: 
About 0.5gram of the powdered leaf was boiled gently for 2 minute with 20 ml 
of water and filtered while hot and allowed to cool. 5ml of the filtrate was then diluted 
with water and shaken vigorously. 
DETERMINATION OF FOAMING INDEX: 
One gram of the coarsely powdered leaf was weighed and transferred to 500 
ml conical flask containing 100 ml of boiling water. The flask was maintained at 
moderate boiling, at 80-90oC for about 30 minutes. Then it was cooled and filtered 
into a volumetric flask and sufficient water was added through the filter to make up 
the volume to 100 ml (V1). 
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Ten Stoppard test tubes were cleaned (height 16 cm, diameter 1.6 cm) and 
marked from 1 to 10. Measured and transferred the successive portions of 1, 2, 3ml 
up to 10ml and adjusted the volume of the liquid in each tube with water to 10ml. 
Then the tubes were Stoppard and shaken lengthwise for 15 seconds, uniformly and 
allowed to stand for 15 minutes and measured the length of the foam in every tube. 
TEST FOR TANNINS: 
To the aqueous extract of the powdered leaf, few drops of ferric chloride solution 
were added. 
 GOLD BEATER’S SKIN TEST: 
 2% hydrochloric acid was added to a small piece of gold beater skin and 
rinsed with distilled water and placed in the solution to be tested for five 
minutes. Then washed with distilled water and transferred to a 1% ferrous 
sulphate solution. 
TEST FOR PROTEINS AND FREE AMINOACIDS: 
 MILLON’S TEST: 
The acidulous alcoholic extract of the powdered leaf  was heated with 
Millon’s reagent. 
 BIURET TEST: 
To the alcoholic extract of the powdered leaf 1ml of dilute sodium 
hydroxide was added. Followed by this one drop of very dilute copper sulphate 
solution was added. 
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 NINHYDRIN TEST: 
To the extract of the powdered drug, Ninhydrin solution was added, and 
boiled. 
TEST FOR MUCILAGE: 
To the aqueous extract of the powdered leaf, Ruthenium red solution was 
added. 
TEST FOR FLAVONOIDS 
SHINODA TEST: 
A little amount of the powdered leaf was heated with alcohol and filtered. To 
the alcoholic solution a few magnesium turnings and few drops of 
concentrated hydrochloric acid were added, and boiled for 5 minutes. 
ALKALINE REAGENT TEST: 
To the alcoholic extract of the powdered leaf, few drop of sodium hydroxide 
solution was added. 
ZINC HYDROCHLORIDE TEST: 
To the alcoholic extract, mixture of zinc dust and concentrated 
Hydrochloric acid was added. 
TEST FOR TERPENOIDS: 
The powdered leaf was shaken with petroleum ether and filtered. The filtrate 
was evaporated and the residue was dissolved in small amount of chloroform. To the 
chloroform solution tin and Thionyl chloride were added. 
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TEST FOR VOLATILE OIL: 
About  100gram  of  fresh  leaves,  were  taken  in  a  volatile  oil  Clevenger 
apparatus and subjected to hydro distillation for four hours. 
TEST FOR FIXED OIL: 
A small amount of the powdered leaf was pressed in between in the filter 
paper and the paper was heated in an oven at 105oC for 10 minutes. 
4.3.2. FLUORESCENCE ANALYSIS OF POWDERED LEAF: 
Powdered leaf material of C.halicacabum was subjected to analysis under UV 
light after treatment with various chemical and organic reagents like Ethanol, Ethyl 
acetate, Chloroform, Water, 50% sulphuric acid, 10% sodium hydroxide, 50% nitric 
acid and dried leaf powder. (Horbone, JB, 1973). 
PREPARATION OF ETHANOLIC EXTRACT 
The Leaf Powder was sieved in a no.60 sieve and refluxed with ethanol for 
4hrs and filtered. The filtrate evaporated under vacuum. The dark green residue 
obtained (EECH) was stored in the refrigerator until further use. 
4.3.3. ESTIMATION OF FLAVONOID CONTENT: 
(Chang, CC et al., 2002, Mabry, TJ et al., 1970 and Siddiquie, MA et al., 
2010).he flavonoid content of plant extract was estimated by aluminium chloride 
method. In this method, aluminium chloride complexes with flavonoids of C3-C5 
hydroxyl group and to produce intense colour in acidic medium. The intensity of the 
color is proportional to the amount of flavonoids and can be estimated as quercetin 
equivalent at wavelength of 415nm. 
DEPARTMENT OF PHARMACOGNOSY MMC,MADURAI Page 70 
CHAPTER IV MATERIALS AND METHODS 
MATERIALS REQUIRED: 
Ethanolic extract of leaves of C.halicacabum (EECHL) 
10%w/v aluminium chloride 
1M Potassium acetate 
95%v/v ethanol 
PROCEDURE: 
0.5ml of the extract (1mg/ml) was transferred to a test tube. To this solution, 
0.1ml of aluminium chloride, 0.1ml of potassium acetate, 1.5ml ethanol were added 
and made up to 5ml with distilled water. The mixture was allowed to stand for 30 min 
with intermittent shaking. The absorbance was measured at 415nm. The calibration 
curve was generated using quercetin as a standard at different concentrations (5- 
50µg/ml). The reaction mixture without aluminium chloride was used as a blank. The 
flavonoids content was expressed as mg of quercetin equivalent per gram of extract. 
4.3.4. ESTIMATION OF TOTAL PHENOLIC CONTENT (Singleto, VL, et 
al., 1979, Gouthamchandra, K, et al., 2010) 
PRINCIPLE: 
The total phenolic content of the extract was determined by Folin & Cio- 
calteu’s phenol reagent. This reagent consists of phosphotungstate and 
phosphormolybdate mixture which is reduced to mixture of blue molybdenum and 
tungsten oxides while phenolic content of the extract was oxidized. The intensity of 
color is proportional to the amount of phenolic content of the extract and which was 
measured at 765nm. The total phenolic content in the extract was expressed as 
milligrams of gallic acid equivalent (GAE) per gm of extract. 
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MATERIALS: 
Ethanolic extract of leaves of C.halicacabum (EECH) 
10%w/v sodium carbonate solution 
Gallic acid 
Folin&Cio-21021calcateu’s phenol reagent 
PROCEDURE: 
0.5ml and 1ml of extract was transferred into separate test tube. To this 
solution, FCR 0.5ml and 1ml of sodium carbonate were added and final volume 
made up to 10ml with distilled water. The mixture was allowed to stand for 1hr with 
intermittent shaking. The absorbance was measured at 765nm. A calibration curve 
was generated using Gallic acid as a standard at different concentrations (2, 4, 6, 8, 
10µg/ml).  The  reaction  mixture  without  sample  was  used  as  a  blank.  The  total 
Phenolic content was expressed as milligrams of Gallic acid equivalent (GAE) per g 
of extract. 
4.3.5 DETERMINATION OF TRACE ELEMENTS IN THE LEAF OF 
C.halicacabum BY ENERGY DISPERSIVE X-RAY SPECTROMETER 
(EDS): 
The SEM allows the observation of materials in macro and submicron ranges. 
SEM is capable of generating 3-D images for analysis of topographic features. When 
SEM is used along with EDS the analyst can perform an elemental analysis on 
specimens of microscopic sections or contaminants that may be present. 
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EDS ANALYTICAL CAPABILITIES: 
Backscattered electron images in the SEM display compositional contrast that 
results from different atomic number elements and their distribution. EDS is used to 
find  particular  elements  are  and  their  Atomic  %.  The  Y-axis  shows  the  counts 
(number of X-rays received and processed by the detector) and the X-axis shows the 
energy level of those counts (Bob Hofner). 
By Viewing 3-D images of  specimens solves some of the problem in an 
analysis and it is also necessary to detect different elements associated with the 
specimen. This is accomplished by using the “built-in” spectrometer called an Energy 
Dispersive X-ray Spectrometer. 
EDS SYSTEM COMPRISES OF 3 BASIC COMPONENTS: 
An X-ray Detector - detects and converts X-ray into electronic signals. 
A Pulse Processor - measures the electronic signals to find out energy of each 
X-ray detected; and 
A Multiple Channel Analyser - interprets and displays analytical data. 
EDS is an analytical technique in which the specimen emits X-rays due to the 
bombardment  of  electron  beam  on  it  which  is  used  to  identify  the  elemental 
composition of the specimen due to the ejection of electrons from the atoms on the 
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specimen surface. To explain further, when the sample is bombarded by the electron 
beam of the SEM, electrons are ejected from the atoms on the specimen’s surface. A 
resulting electron vacancy is filled by an electron from a higher shell, and an X-ray is 
emitted to balance the energy difference between the two electrons. The EDS X-ray 
detector measures the number of emitted X-rays emitted versus their energy. The 
energy of the X-ray is characteristic of the element from which the X-ray was emitted. 
A spectrum of the energy versus relative counts of the detected x-rays is obtained 
and evaluated for the determinations of the elements. 
4.3.6 HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY OF 
THE EECH LEAF: 
High performance thin layer chromatography (HPTLC) is a modern 
adaptation of TLC with improved versatility, separation efficiency and detection limits. 
HPTLC is a useful tool for identification of plant extract because each plant species 
produces a distinct chromatogram, with unique marker compounds used for the plant 
identification. It is used as a quality control tool since comparison of chromatograms 
of different lots can demonstrate the similarities and differences between the test 
samples  and  their  standard  chemical  markers.  HPTLC  is  a  reliable  method  for 
quantification of nano gram level even when present in complex formation. HPTLC 
fingerprint analysis is used for rapid identity Check, for monitoring purity of drugs, for 
detection of adulterants, for determining whether material is derived from a defined 
botanical species and also to know whether the constituents are clearly 
characterized.(Wagner,H et al,1996) 
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HPTLC PROFILE : 
Instrument used : CAMAG make HPTLC. 
Software : winCATS 1.4.3 
Sample Applicator : Linomat 5. 
Detection : @254nm  in  Densitometry  TLC Scanner 
Sample preparation : 100mg per ml of sample was 
prepared in Ehanol. 
Stationary Phase : HPTLC plates silica gel 60 F 254. 
Mobile Phase : Chloroform:methanol:water. (6:3.5:0.5). 
Sample Solution : 5µl sample is applied. (1µg/ml) 
Standard solution : 5µl sample is applied. (1µg/ml) 
Drying device : Oven 
Temperature : 60°C 
Time : 5minutes 
Scanning speed : 20mm /s 
MEASUREMENT TABLE 
Wavelength  : 254 
Lamp : D2 & W 
Measurement type : Remission. 
Measurement mode: Absorption. 
DEPARTMENT OF PHARMACOGNOSY MMC,MADURAI Page 75 
CHAPTER IV MATERIALS AND METHODS 
4.4 PHARMACOLOGICAL STUDIES 
4.4.1. ACUTE TOXICOLOGICAL STUDIES : 
Toxicology through intensive studies has traditionally focused on the effects of 
chemicals on living organisms which was done by one chemical at a time. Such 
approaches show the mode of action of many chemicals and provide a detailed 
mechanistic understanding of the molecular targets of toxicity for some as the cost of 
this approach is high. Toxicology studies rely on the utility of vertebrate animals 
which is an expensive undertaking in both time and cost with debatable predictive 
power in case of safety aspects for human (Bucher, JR 2002). 
Role of zebrafish in high throughput screening 
In the last two decades safety pharmacology has become a most important 
part of the non-clinical safety assessment in finding new chemical entities (Bass, A et 
al., 2004). 
The relative novelty of this discipline has granted it the flexibility to incorporate 
new experimental tools (Claude, JR and Claude, N 2004). 
In  addition  to  requiring  small  amount  of  compounds,  the  time  and  cost 
effectiveness of in vitro assays have led to their use by the pharmaceutical industry 
for high or medium throughput safety screens (Suter, W 2006). 
One of the limitations encountered with in vitro studies is that they are not fully 
representative of in vivo models. Therefore, safety pharmacology needs an in vivo 
model with the capacity for higher throughput screening. The zebrafish model system 
is done from medium to high throughput because of many advantages, as they are 
small in size, cheap to maintain and fecundity as a single spawning produces 100– 
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200 eggs. Larvae, which are only 1–4-mm long, can live for seven days in a single 
well of a standard 96-or 386-well microwell titer plate by the support of nutrients 
stored in the yolk sac. 
Administration of drugs in zebrafish 
Larvae  of  zf  can  absorb  small  molecules  diluted  in  the  surrounding  water 
through their gills and skin. Drugs can be given orally after this stage because 
zebrafish begin to swallow at 72 (hpf). Drugs can also be delivered by oral intubation 
in  case  of  adult  zf.  Compared  to  testing  in  other  animal  models,  statistically 
significant numbers of zebrafish can be used for each assay and small amounts (mg) 
of drug are required. In addition, the transparency of zebrafish larvae for several days 
of post fertilization (dpf) enables in vivo observation of live or whole mount fixed 
specimens, including the visualization of vital dyes, fluorescent tracers, antibodies 
and riboprobes. By 120 hpf, zebrafish develop discrete organs and tissues, including 
brain, heart, liver, pancreas, intestines, bone, muscles, nerve systems and sensory 
organs. These organs and tissues have been shown to be similar to their mammalian 
counterparts at  the  anatomical,  physiological  and  molecular  levels.  Although 
conventional in vitro assays using cultured cells can be used to evaluate potential 
drug toxicity effects, results are frequently not predictive of results in vivo which 
involve drug absorption, distribution, metabolism and excretion (ADME). To 
streamline  the  drug  development  time-line,  prioritize  drug  candidates  for  animal 
testing and reduce unnecessary costs for mammalian studies, drug-screening assays 
using zf are becoming increasingly popular (McGrath P and Chun-Qi Li 2008). 
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Morphology of zf larva 
Fig-1 
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Fig-2 
Digestive system anatomy of zf larva 
The  zf  intestinal  epithelium  is  comprised of  absorptive  cells  (enterocytes), 
endocrine cells and goblet cells. When zf larvae consume a lipid rich diet it must be 
broken down by luminal lipases into free fatty acids and cholesterol in the intestine 
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before entering the specialized absorptive cells (enterocytes) that line the gut (Pack, 
M et al., 1996). 
Zebrafish cardiovascular development and anatomy 
As  in  all  vertebrates,  the  heart  is  the  first  organ  to  function  in  zf.  It 
develops rapidly and is fully formed by 2dpf, compared with 12dpf in the mouse and 
35dpf in the human embryo at 3 weeks gestation. zf hearts, like those of humans, 
start out as a linear heart tube and start to loop 24-36 hour post fertilization (hpf). 
Zf cardiac contraction begins at 22hpf initially as a peristaltic wave which then 
develops into co- contractions of the ordinate atrium and ventricle by 36hpf. Blood is 
first sent from the heart to the gills where it is oxygenated. It then passes to the head 
before moving posteriorly to the rest of the body. Despite the lack of a pulmonary 
circulation and its two chambered heart, there is significant conservation between 
mammalian  and  zf  cardiovascular  development  at  morphologic,  physiologic  and 
genetic level, making it an useful model for studying cardiac development (Dooley, K 
and Zon, LI 2000). 
Collection of ZF larvae: 
Zf spawn in the morning and the embryos are collected from the bottom of 
the  tank  and  transferred  into  a  petridish  and  incubated  in  vitro  using  standard 
medium. Embryos hatch from the chorion at around 48 hour post fertilisation (hpf) 
and the larvae are incubated at 28ºC. By 5-6dpf the yolk has been depleted and 
larvae must now eat to acquire nutrients (Munoz,G et al., 1990). 
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4.4.1.1 WHOLE EMBRYO CULTURE TOXICITY STUDY 
Materials 
Fertile eggs, E3 embryo medium (standard medium), Dimethyl Sulphoxide 
(DMSO),  glass  petridishes,  research  microscope  (laboscope  microscope  with 
microphotography), incubator, micropipette, EECH of C.halicacabum  and standard 
podophyllotoxin. 
Collection of eggs 
Eggs were collected from natural spawning and reared in embryo medium at 
pH 7.2, and kept in an incubator at 28±0.5°C for our assay. The developmental stage 
of the embryos was determined using microscope. (Hisaoka, KK and Battle, HI 
1958). (Fig - 2) 
At around 2– 4 h postfertilization, only the fertilized eggs (blastula stage) were 
selected. The fertilized eggs were collected and rinsed several times with tap water. 
Experimental design 
The  eggs  were  transferred  to  each  of  the  glass  petri-dishes  (3  per  dish) 
containing different concentrations of EECHL (0.5, 0.75, 1 and 2 μg/ml ) dissolved in 
1% DMSO at 28°C as well as DMSO control . Embryo medium served as the over-all 
control .Standard podophyllotoxin of concentration 10 μg/ml was taken as positive 
control. Occasional stirring was done to ensure even distribution of the chemical. The 
maximal  acceptable  toxicant  concentration  (MATC)  was  calculated  according  to 
(Dave, G et al., 1987) by scoring the malformations. The development of blastula 
eggs was monitored at specified time points (12, 36, 60 & 80 hrs) under microscope. 
Endpoints used for assessing the effect of drug during the major organ is visible 
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included edema, eye malformation, bent tail, undulated notochord, twisted notochord 
and death. Malformations were also noted and described among the juveniles from 
the control 1% DMSO treated and standard podophyllotoxin . 
4.4.1.2 LARVAL TOXICITY STUDY 
Materials 
Zf larvae of 5dpf, E3 embryo media (standard medium), 1% DMSO, glass 
petridishes, research microscope (laboscope microscope with microphotography), 
incubator,  micropipette,  ethanol  extract  from  the  leaves  of  C.halicacabum  and 
standard podophyllotoxin. 
Experimental design 
Healthy 5dpf zf larvae were selected and used for larval toxicity study. About 5 
larvae were  released in  the  embryonic medium (10 ml) taken in a petridish, in 
triplicate. Various concentration of EECHL  (0.5 and 0.75, 1 and 2 mg/ml) dissolved 
in 1% DMSO in the embryonic medium were tested. Two controls were used DMSO 
and  embryonic  medium  respectively.  Podophyllotoxin  (10  μg/ml)  was  used  as 
standard toxin . 
Lethality concentration determination 
The percentage lethality was determined by comparing the mean surviving larvae 
of the test and control vials. Graph was plotted, concentration versus percentage 
lethality. Podophyllotoxin was used as a positive control in the bioassay. 
The percentage lethality was calculated from the mean survival larvae of various 
concentrations of EECH treated dishes and control. The corrected(%) mortality was 
calculated by using Schneider-Orelli’s formula. 
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Corrected %= Mortality(%) in Treated – Mortality (%) in Control x 100 
100 –Mortality (%) in Control 
Even though lipids play a vital role in the cellular function, it is not surprising that 
defects in lipid metabolism underlie many human diseases. More than a third of 
adults  and  17%  of  children  are  currently classified  as  obese.  This  study  was 
focussed on the inhibition of absorption of dietary lipid in the intestine of zf that 
provides an invivo environment as well as the potential for high throughput drug 
screening. 
Observation Of Feeding Habit 
5dpf zf larvae was fed with yolkmass in a petridish. After allowing time for its 
absorption (2-3 hrs), larvae from the petridish was collected and examined under 
research microscope to see the presence of intestinal yolkmass. Yolkmass within the 
intestinal lumen was detected and the expulsion of unabsorbed food material was 
also seen, which shows that the nutrient has been absorbed in the intestine and 
reaches the blood circulationZEBRAFISH HANDLING (Zhou, J et al., 2015,Cliton D 
et al.,2010) 
200-300embryos  were  maintained  at  28°C  in  fish  water  (0.2%  salt  in 
deminerolized water, pH 6.9-7.2) and the embryos were collected. 
4.4.2 ASSESSMENT OF DRUG EFFECT ON ZEBRAFISH BLOOD LIPIDS 
Zf larvae were fed with egg yolk for 48hr, followed by drug treatment for 24hr 
and 48hr at 3 concentrations. At the end of treatment, ORO was used to stain the 
lipids of Zf larvae. Fifteen to twenty Zf larvae from each group were randomly chose 
for ORO image acquisition. Zf larvae were immobilized in 3% methyl cellulose and 
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images  were  acquired  in  the  identical  lighting  intensity  under  light  microscope 
installed with a high speed video camera linked with computer system. When viewed 
dorso-laterally, the blood vessel of an 8 or 9 dpf Zf larvae was situated posterior to 
clocal pore and predominantly anterior to the tail fin. Quantitative image analysis  of 
ORO was performed and Integrated Option Density (IOD) data were expressed as 
mean ±SEM. The effect of test drug EECHL  was calculated based on the following 
formula. 
Drug effect on lipids lowering (%) = (1-IOD compound/IOD vehicle)x100%. 
To determine the statistical significance One way Anova is used to compare the 
differences among groups using SPSS 16.0 software. 
4.4.3. EFFECT OF EECH ON THE CVS (HEART RATE, CARDIACMORPHOLOGY 
AND BLOOD CIRCULATION) OF ZEBRAFISH LARVAE 
Cardiac function assessment 
Hiperlipidemia zf larvae of 5dpf were placed in 96 well plates, at 1 larvae per 
well which different concentration of EECH (0.5, 0.75, 1 and 2mg/ml) (test). The 
larvae fed with normal diet (paramecia) in embryonic medium serve as the control. 
The cardiac function assessment was performed for normal diet and yolk mass fed 
larvae.  All  zf  larvae  were  exposed  for  3  hrs.  Then  they  were  immobilized  in 
methylcellulose (3% w/v) and the heart rate per minute for each larva was recorded 
by eye under a research microscope. Cardiac morphology and blood circulation were 
observed. The test was performed in duplicate 
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CHAPTER V RESULTS 
CHAPTER V 
RESULTS 
5.1 PHARMACOGNOSY 
 
5.1.1 MORPHOLOGICAL FEATURES OF Cardiospermum 
 
halicacabum (Plate1, Fig-1). 
 
Balloon-vine  is  a  perennial  creeper  at  its  base,  the  plant’s  stem  is  only 
approximately 3mm thick, but it can reach a height of up to 2 metres. The stem forms 
internodes of between 5-10 cm in length.The grooved stem carries alternate double 
triad leaves, 3 to 5 cm long, which are hairless or covered in a soft down of hairs. 
LEAF: A pubescent or nearly globrous annual or perennial with slender branches 
 
climbing by means of tendriller (Plate-2,3) 
Arrangement : Ternately bicompound ,biternate essentially 
Shape : Ovate –lanceolate 
Size : 2-4cm in length 
Colour : Pale or light green 
Margin : Dentate irregularly deeply incised 
Apex : Acute 
Base : Obtuse-turncate beneath 
STEM 
Colour 
 
Shape 
: Green colour 
 
: stems with minutely puberulous,sometimes slightly 
woody; 
Tendrils present,5 or 6-sulcate, slender,glabrous or 
sparesly hairy 
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FLOWERS(Plate-4) 
Description: Axillary heads  usually 3 flowerd by abortion,  white  with 
yellowish centre Irregular flowers are borne in panicles (3, 6). Each flower bears four 
sepals, two large and two small, four whitish petals,. Petaloid appendages are at the 
base of each flower. 
Size : 4mm long 
Colour : Milky white 
Ovary : 3-celled ovary bears one ovule per cell 
Stamens : 8 stamens present 
FRUITS(Plate-5) 
Shape : Inflated , papery capsule 
Size : 3 chambers, 3-4.5 cm in diameter 
Colour : Before ripe- green colour ,After ripe-s 
light yellow colour 
Ribes : 8-10 prominent longitidunal ribes not covered with 
spines or  Papillae 
SEEDS (Plate-6) 
Shape : Opaque,finely porous heart shape 
Colour : Black,smooth with white, Size : 5mm diameter 
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5.1.2 MICROSCOPY OF THE LEAF 
 
Leaf is dorsiventral and prominent. 
LEAF MIDRIB (Plate-7,Figure-2) 
It is projecting both adaxial and abaxially. The adaxial part is thick and pyramid 
like but abaxial part is semicircular with undulate outline. The inner part of the adxial 
cone includes a cluster of angular collenchyma cells. The palisade is extended up to 
the shoulders of the cone. The vascular strand is fairly prominent and is triangular in 
shape comprises a cluster of wide circular thin walled xylem elements and a thick 
band of phloem elements. 
EPIDERMIIS IN SURFACE VIEW (Plate-8) 
Fairly large squarish thick walled cells. The abaxial epidermal cells are thin, 
small and elliptical. Paradermal section shows epidermal cells wide with highly wavy 
anticlinal walls and amoeboid outline. The stomata is dense and diffuse in distribution 
and are anomocytic type. The guard cells are elliptical and the stomatal pores are slit 
like. 
LAMINA (Plate-9) 
The mesophyll is differentialted into upper band of narrow cylindrical palisade 
cells  and  lower  zone  of  two  or  three  layers  of  lobed  loosely  arranged  spongy 
parenchyma cells. The lateral veins are conspicuous, straight and uniformly thin. The 
vein islets are distinct having straight vein boundaries. Vein termination are present 
in the islets some places branched once or twice and spread within the islets. 
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T.S OF PETIOLE:(Plate-10,Figure-3) 
It shows two prominent grooves towards upper side where as the lower side is 
round.  The  epidermis  is  composed  of  single  layer  of  cells.  Chlorenchymatous 
hypodermis is present. 4-6 collateral vascular bundles are present in the ground 
tissue. The xylem is present upper side and phloem towards the lower side. The 
ground tissue is made up of parenchyma cells. 
T.S OF RACHIS:(Plate-11) 
Polygonal in outline with two winged projections at the upper side. Single layer 
of  epidermal  cells  composed  of  horizontally  flattend  cells  with  cuticle.  Covering 
unicellular trichomes are present.  Peripheral layer of ground tissue are composed of 
collenchymatous and chlorenchymatous cells forms the hypodermis.  A continuous 
ring of pericyclic fibres is present in the ground tissue. Vascular bundles are arranged 
in a ring and are collateral. The rest is parenchymatous. 
5.1.3 MICROSCOPICAL STUDY OF LEAF USING SCANNING 
ELECTRON MICROSCOPE. (Plate-12,13) 
SEM  microscopy  when  applied  to  the  surfaces  of  the  leaf  revealed  the 
presence of unicellular trichome and ranunculaceous or anomocytic stomata and 
their distribution. 
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5.1.4 POWDER MICROSCOPY (Fig-4) 
ORGANOLEPTIC CHARACTERS 
1.Nature : Coarse powder. 
2.Color : Dark green. 
3.Odour : Charecterstic odour. 
4.Taste : Tasteless 
5. Pressed in between two filter paper: No oil mark on the paper. 
We have observed the following microscopical cell structures, 
Ranunculaceous stomata (Anomocytic),  
 Parenchyma, 
Xylem vessels,  
 Fibers, 
 Collenchyma, 
Uniseriate,multicellular trichomes.  
5.1.5 MICROSCOPIC SCHEDULES 
As per the methods described in materials and methods, microscopic schedule was 
carried  out  and  the  results  were  tabulated  from  the  Tables  1-4.  The  following 
evaluation were carried out. 
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Table – 1 
 
 
VEIN ISLET AND VEIN TERMINATION NUMBER OF C.halicacabum 
LEAVES  
 
 
      
Observation Vein Islet Number  Vein Termination  
 
Number   Number  
 
1 
13 
 
 
12 
  
  
 
    
 
2 11 
 
13 
  
  
 
    
 
3 15                  17     
 
    
 
4 14 
 
                18 
  
  
 
    
 
5 15 
 
12 
  
  
 
    
 
6 10 
 
14 
  
  
 
    
 
7 11 
 
11 
  
  
 
    
 
8 12 
 
                15 
  
  
 
    
 
9 17 
 
                  10 
  
  
 
       
 
10 22 
 
               16 
  
  
 
     
  
 
 
 
Range Minimum Average Maximum 
Vein Islet 
Number 
10 15 22 
Vein 
Termination 
10 13 18 
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Table – 2 
 
 
STOMATAL NUMBER OF C.halicacabum 
 
 
   
Observation Lower Upper 
Number Epidermis Epidermis 
   
1 22 25 
   
2 19 23 
   
3 21 24 
   
4 18 23 
   
5 20 26 
   
6 29 27 
   
7 27 28 
   
8 26 21 
   
9 30 20 
   
10 18 22 
    
 
 
 
Range Minimum Average Maximum 
Lower Epidermis             18      22 30 
Upper Epidermis 20      23 28  
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Table – 3 
 
 
STOMATAL INDEX OF C.halicacabum    
 
   
Observation Lower Upper 
Number Epidermis Epidermis 
   
1 10 11.9 
   
2 10.3 12.1 
   
3 9.9 12.4 
   
4 10.5 12 
   
5 10.7 12.5 
   
6 10.9 12.7 
   
7 11 11.7 
   
8 11.3 13 
   
9 12 13.1 
   
10 11.8 13.5 
    
 
 
 
Range Minimum Average Maximum 
Lower Epidermis 9.9 10.7 12 
Upper Epedermis 11.7 12.5 13.5  
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Table – 4 
 
 
PALISADE RATIO OF C.halicacabum 
 
 
  
Observation Upper 
Number Epidermis 
  
1 6.7 
  
2 7 
  
3 6.8 
  
4 7.7 
  
5 7.5 
  
6 6.7 
  
7 6.9 
  
8 7.6 
  
9 7.8 
  
10 7.9 
   
 
 
Range Minimum Average Maximum 
Lower Epidermis 6.7 7.5 7.9  
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5.1.6 PHYSICO CHEMICAL PARAMETERS 
 
 
As per the methods described in materials and methods, physico chemical 
parameter was carried out of quantitative microscopy and the results were tabulated 
from the Tables 5-7. The following evaluation were carried out. 
 
Table – 5 
 
ASH VALUE FOR THE LEAVES OF C.halicacabum 
 
         
 Observation  Total Ash  Acid Insoluble  Water Soluble  
 Number (%)  Ash (%)  Ash (%)  
 1 5 0.94 -  
         
 2 7.6 1 -  
         
 3 7.5 0.97 -  
         
 4 6.8 1.03 -  
         
 5 7.05 1.10 -  
         
 6 6.9 - 4.04  
         
 7 7 - 4.09  
         
 8 7.1 - 4.08  
         
 9 7.3 - 4.07  
         
 10 7.02 - 4.12  
         
         
 Minimum  5  0.94  4.04  
         
 Average  6.8  1  4.08  
         
 Maximum  7.6  1.10  4.12  
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Table – 6 
 
 
PERCENTAGE OF LOSS ON DRYING FOR THE LEAVES OF C.halicacabum 
 
 
      
Observation Number Loss on Drying (%) W/W 
     
   Leaf  Powder 
      
 1  6.08 
      
 2  6.53 
      
 3  6.72 
      
 4  7.01 
      
 5  6.63 
      
Material  Minimum Average  Maximum 
      
Leaves  6.08 6.72  7.01 
powder      
 
 
 
Table – 7 
 
 
EXTRACTIVE VALUES (INDIVIDUAL SOLVENTS) 
 
Solvents Extractive value (%)w/v 
Ethanol 13.5 
Water 10.3 
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5.2. PHYTOCHEMICAL SCREENING 
5.2.1. Preliminary Photochemical Screening 
Preliminary phytochemical screening of the powdered mature leaves were 
carried out and the results are as follows (Table 9-10) 
 
TEST FOR ALKALOIDS 
 
 
Mayer’s Test : Cream precipitate shows the Presence of 
  alkaloids. 
Dragendorff’s Test : Reddish brown precipitate shows the 
  Presence of alkaloids. 
Hager’s Test : Yellow precipitate shows the Presence of 
  alkaloids. 
Wagner’s Test : Reddish brown precipitate shows the 
  Presence of alkaloids. 
 
 
TEST FOR CARBOHYDRATES 
 
                                                        
 
Molish’s Test : 
Appearance of purple color shows the Presence 
Of carbohydrate 
 
 
Fehling’s Test : Formation of reddish brown precipitate shows the 
  Presence  of free reducing sugars. 
Benedict’s Test : Formation of reddish brown precipitate shows the 
  Presence of free reducing sugars. 
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TEST FOR GLYCOSIDES 
 
 
Test A 
 
 
 
: 
 
 
 
No red color precipitate shows the Absence of 
glycosides. 
 
Test B 
 
: 
 
Appearance of red color precipitate less than test A 
shows the Absence of glycosides 
  
Anthraquinone glycosides 
Borntrager test  :  No pink color in ammonical layer 
 shows the Absence of anthraquinone 
 glycosides.  
Modified borntrager’s test  :  No pink color in ammonical layer 
 shows the Absence of anthraquinone 
 glycosides.  
Murexide test  : No appearance of purple color shows 
 
 the Absence of purine alkaloids 
  Keller killiani’s test        :  No reddish brown color ring at the junction 
   shows the Absence of cardiac glycosides. 
Raymond’s test :  No violet color shows the Absence of 
   cardiac glycosides. 
Legal’s test :  No blood red color shows the Absence of 
   cardiac glycosides. 
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TEST FOR CARDIAC GLYCOSIDES: 
 
TEST FOR PHYTO STEROLS 
 
 
Salkowski’s test 
 
 
 
: 
 
 
 
Apprearance of red colour in lower layer 
shows the Presence of sterol. 
 
 
 
 
 
Libermann-Burchard’s test       : 
 
Brown ring at the junction of two layers and 
the appearance of green colour in the upper 
layer shows the Presence of sterols.
 
 
TEST FOR SAPONINS     :        Froathing occurs indicates the Presence  
of saponins. 
 
TEST FOR TANNINS 
 
 
Ferric chloride test 
 
 
 
: 
 
 
 
Appearance of bluish black color shows the 
Presence of tannins. 
 
Gold beater’s skin 
 
: 
 
Appearance of brown color shows the 
Presence of tannins. 
 
 
TEST FOR PROTEINS AND FREE AMINO ACIDS 
 
 
Millon’s test 
 
 
 
: 
 
 
 
Appearance of red color on heating shows 
the Presence of proteins. 
 
Biuret test 
 
: 
 
Appearance of violet color shows the 
Presence of proteins. 
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Ninhydrin test 
 
: 
 
Formation of violet color shows the 
Presence of amino acids. 
 
TEST FOR MUCILAGE          : 
 
Appearance of reddish pink color shows the 
Absence of mucilage. 
 
TEST FOR TERPENOIDS         :         Appearance of pink color shows the   
Presence of terpenoids. 
 
TEST FOR FLAVONOIDS 
 
 
Shinoda test 
 
 
 
:     Appearance of purple color shows the 
Presence of flavonoids                
 
Alkaline reagent test 
 
:    Appearance of yellow orange color 
 shows  the Presence of flavonoids 
 
Acid test 
 
  :    Appearance of yellow orange color shows the    
              
       Presence of flavonoids. 
 
 
 
Zinc HCL test  
  
  :  Appearance of red color shows the     
Presence of flavonoids 
 
TEST FOR VOLATILE OIL :    Volatile oil not obtained shows the  
absence of volatile oil. 
  
 
TEST FOR FIXED OIL  : No translucent greasy spot shows the  
absence of fixed oil. 
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RESULTS FOR THE PRELIMINARY PHYTOCHEMICAL SCREENING OF 
LEAVES OF C.halicacabum.  
      
 S.NO TEST OBSERVATION  
 I. ALKALOIDS    
  Mayer’s reagent  +  
  Dragendroff’s reagent  +  
  Hager’s reagent  +  
  Wagner’s reagent  +  
  Murexide Test  -  
 II. CARBOHYDRATES    
  Molisch’s test  +  
  Fehling’s test  +  
  Benedict’s test  +  
 III. GLYCOSIDES    
  Anthroquinone glycosides  -  
  Borntrager’s test  -  
  Modified Borndrager’s test  -  
  Cardiac glycosides    
  Keller Killiani test  -  
  Raymond test  -  
  Legal test  -  
 IV. STEROLS    
  Salkowski test  +  
  Lieberman Burchard’s test  +  
 V. SAPONINS  +  
 VI. TANNINS    
  Ferric chloride  +  
  Gold Beater’s skin test  +  
 VII. PROTEINS AND FREE AMINO ACIDS    
  Millon’s test  +  
  Biuret test  +  
  Ninhydrin test  +  
 VIII. MUCILAGE  -  
 IX. TERPENOIDS  +  
 X. FLAVONOIDS    
  Shinoda test  +  
  Alkali test  +  
  Acid test  +  
  Zn/Hcl test  +  
 XI. VOLATILE OIL  -  
 XII. FIXED OIL  -  
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5.2.2 FLUORESCENCE ANALYSIS OF POWDERED LEAF 
 
 
The fluorescence analysis of the leaf powder of C.halicacabum was studied. 
The results were as follows (Table 9) 
 
TABLE – 9 
 
FLUORESCENCE ANALYSIS 
 
      
No Treatment  Visible light UV 254 nm UV 366 nm 
      
1 Powder  Light  green Green 
Brownish 
green 
      
2 Powder + Green Black 
Greenish 
black 
 1N NaoH     
      
3 
Powder 
+Picric acid  Green+ yellow Black Green Black 
     
      
4 Powder + Green brown Black green Green or grey 
 Acetic acid     
      
5 Powder + 
Brownish 
green Black green Black 
 1N HCL     
      
6 Powder + Green brown Black Green Black 
 1N HNO3     
      
7 Powder + Brown Green Dark brown Black 
 5 Iodine     
      
 
 
PREPARATION OF EXTRACT EECHL 
Dark green viscous residue obtained 13.5%w/v. 
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5.2.3 ESTIMATION FO FLAVONOID CONTENT 
Flavonoid content of EECHL   was found to be 1.06 mg/g. 
5.2.4 ESTIMATION OF TOTAL PHENOLIC CONTENT 
Total phenolic content of EECHL was found to be 38.05 mg/g. 
5.2.5 DETERMINATION OF TRACE ELEMENTS IN THE LEAF OF 
C.halicacabum BY ENERGY DISPERSIVE X-RAY SPECTROMETER 
(EDS). 
Estimation of the elements like C, O, Mg, P, Cl, K, Cl, Ca showed the following mg 
weight percentage and atomic percentage. 
FIG: 5  
ENERGY DISPERSIVE X-RAY SPECTRUM FOR  
C.halicacabum LEAVES 
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TABLE 10 
 
C.halicacabum  LEAVES ELEMENTS WEIGHT PERCENTAGE 
 
   
S.NO ELEMENTS WEIGHT 
  (%) 
1 CK 53.67 
   
2          OK 44.05 
   
3 MgK 0.18 
   
4 P K 0.36 
   
5 Cl K         0.18 
   
6          K K 1.27 
   
7 Ca K 0.28 
   
  
5.2.6 HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY OF 
THE EECHL 
About 5 µl of standard Pinitol, 6µl of EECHL was applied as a band using 
CAMAG Linomat sample applicator on aluminium sheets pre-coated with silica gel 60 
GF 254 HPTLC plates used as a stationary phase. The plates were developed in the 
mobile phase Chloroform:methanol:water (6:3.5:0.5) to a distance of 16.0mm in 
CAMAG trough glass chamber. The tracks were scanned using WIN CATS 1.43 
software at 254nm. The fingerprint profiles were recorded and presented. The plot 
showed 9 spots after development with the mobile phase. The Rf value of  standard 
Pinitol 0.68 and Rf value of standard Pinitol 0.69  of EECHL.(0.142mg/100mg) 
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winCATSPlanar Chromatography Manager 
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FIG-6 
STANDARD PINITOL 
DEPAERTMENT OF PHARMACOGNOSY ,MMC ,MADURAI Page 105 
CHAPTER V RESULTS 
winCATS Planar Chromatography  Manager 
Start 
Rf 
Start 
Heigh 
t 
Max 
Rf 
Max 
Heigh 
t 
Max End 
Rf 
End 
Height 
Area 
% % Peak Area Assigned 
substance 
1 -0.01 0.2 0.00 80.1 12.33 0.03 33.2 1234.8 7.35 unknown * 
2 0.04 31.2 0.06 37.6 5.79 0.07 24.2 817.8 4.87 unknown * 
3 0.11 18.8 0.14 55.5 8.55 0.17 25.8 1581.2 9.41 unknown * 
4 0.25 16.2 0.28 25.2 3.88 0.30 22.3 742.3 4.42 unknown * 
5 0.34 17.3 0.38 61.7 9.50 0.41 2.5 1202.0 7.15 unknown * 
6 0.56 2.5 0.58 13.4 2.07 0.59 8.8 164.5 0.98 unknown * 
7 0.64 19.2 0.69 332.4 51.19 0.76 0.2 10239.8 60.92 pinitol 
8 0.79 0.0 0.82 19.6 3.03 0.85 0.0 465.0 2.77 unknown * 
9 0.86 0.6 0.89 23.9 3.67 0.90 0.6 361.0 2.15 unknown * 
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FIG-7 
HPTLC profile of C.halicacabum 
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5.3 PHARMACOLOGICAL STUDIES 
5.3.1 WHOLE EMBRYO CULTURE TOXICITY STUDY 
Effect of EECHL on the developmental stages of zf embryo was carried out. 
The eggs were cultured in the embryonic medium. The maximal acceptable toxicant 
concentration (MATC) was calculated by scoring the malformation 1% DMSO and 
podophyllotoxin  (0.010µg/ml)  were  used  as  control  and  standard  toxin.  No 
malformations and incidence of mortality was observed up to the 0.5-1.5 µg/ml 
concentration level (Score 0). But medium to strong edema, eye malformation, bent 
tail, weak undulated notochord and twisted notochord were observed from 2 to 
4µg/ml concentration up to 80hpf. No mortality was observed in this concentration 
level. Total mortality was observed in the standard podophyllotoxin at 0.01µg/ml 
concentration (score 40). 
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TABLE 11 
SCORES FOR THE WHOLE EMBRYO TOXICITY 
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Conc. µg/ml 
 
Hours 
 
Score 
 
0.5-0.7 
 
All 
 
Nil 
 
 
 
 
 
 
 
 
1 
 
12 
 
1 
 
36 
 
1 
 
60 
 
2 
 
80 
 
2 
 
 
 
 
 
 
 
 
2 
 
12 
 
5 
 
36 
 
5 
 
60 
 
10 
 
80 
 
13 
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5.3.2 ZEBRAFISH LARVAL TOXICITY STUDY (Fig-8) 
Larval  toxicity  study  was  carried  out  on  zf  larvae  of  5dpf  cultured  in  E3 
embryonic medium. Five larvae per group was taken and treated with 0.5, 0.75, 1 
and 2 µg was taken as a test trail and mortality percentage was calculated. 
From the experiment it was observed that there was no mortality in 0.5 and 
0.75 µg/ml concentrations. But 5% and 10% mortality was observed at 1 and 2 µg/ml 
concentration respectively. No mortality was observed in both the control viz DMSO 
and embryonic medium. 100% mortality was observed in the standard podopyllotoxin 
at 0.5 µg/ml concentration. 
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TABLE-12 
 
ZEBRAFISH LARVAL TOXICITY STUDY 
DEPAERTMENT OF PHARMACOGNOSY ,MMC ,MADURAI Page 111 
CONCENTRATION 
 
(g/ml) 
 
Number of 
Larvae 
 
After 4 
hrs 
 
 
Mortality 
 
Corrected 
Mortality 
  
 
 
0.5 
 
20 
 
 
 
 
Nil 
 
 
 
 
- 
 
 
 
 
Nil 
 
20 
 
20 
 
 
 
 
0.75 
 
20 
 
 
 
 
Nil 
 
 
 
 
- 
 
 
 
 
Nil 
 
20 
 
20 
 
 
 
 
1 
 
20 
 
 
Nil 
1 
 
 
 
 
6 
 
 
 
 
6 
 
20 
 
20 
 
 
 
 
2 
 
20 
 
1 
 
1 
 
0 
 
11 
 
10 
 
10 
 
 
 
 
10.5 
 
20 
 
20 
 
 
 
 
Control 
 
20 
 
 
 
 
Nil 
 
 
 
 
Nil 
 
 
 
 
- 
 
20 
 
20 
 
 
Standard 
Podophylotoxin 
 
20 
 
20 
 
100 
 
 
20 
 
20 
 
100 
 
100 
 
20 
 
20 
 
100 
 
 
 
 
FIGURE-8 
ZEBRA FISH LARVAL MORTALITY STUDY 
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CHAPTER V RESULTS 
5.3.3 EFFECT OF EECHL ON THE CVS (HEART RATE, CARDIAC 
MORPHOLOGY AND BLOOD CIRCULATION) Zf LARVA.(Fig-9) 
5dpf larvae were fed with lipid rich diet containing 100, 150, 200 µg/g of 
EECHL larvae fed with normal diet (paramecia) was also observed. From the result it 
was observed that there was increase in heart rate after a lipid rich diet in the zf 
larvae (220 ±2.1) compared with the normal diet fed larvae (153 ±1.7). Moderately 
elevated heart rate (174±0.96) was observed in the zf treated with 100 µg/g EECHL 
in 0.15 or 1% yolk mass. But no elevated heart rate were observed in the 150, 200 
µg/g of EECHL in yolk mass 160± 1.16, 155± 1.9 respectively. 
DEPAERTMENT OF PHARMACOGNOSY ,MMC ,MADURAI Page 112 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE-9 
EFFECT OF EECHL ON CVS ZF LARVAE 
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5.3.4 ASSESMENT OF LIPID LOWERING EFFECT OF EECHL ON 
HYPERLIPIDEMIC ZEBRAFISH LARVAL MODEL:(PLATE-18,Fig-10). 
The developing embryonic and larval zebrafish are small and translucent, 
enabling non intrusive visualization of organs and biological processes in vivo with a 
high resolution. Therefore we used a high fat diet egg yolk to feed zebrafish  larvae 
and develop a zebrafish hyperlipidemia model and lipids in zf were quantified using 
ORO staining. Feeding zf with egg yolk for 24,48 hrs we found that the lipids of gut 
and blood vessel increased with feeding time and blood lipids engorge uniformly at 
48h of feeding. Further we observed the clearance time of stainable lipids in zf and 
found, after removing egg yolk, that lipids of gut and blood vessel were still abundant 
at 24h and 48 h, lipids were plentiful in gut but poor in vasculature at 72h and gut and 
vessel lipids were almost gone at 96h.Thus we fed zf with 0.1% egg yolk for 48hrs to 
establish hyperlipidemia model for assessing lipid lowering efficacy of test drug in this 
model after drug treatment for 24 and 48h based on quantitative analysis of ORO in 
zf vena caudalis 
To determine whether the zf response to the drugs we treated zf with the 
EECHL  extract  in  three  different  concentration  (100,150  and  200µg/g)  ,  using 
ezetimibe 1µM/ml  as standard drug  were added tp the treatment media at 7dpf and 
were assessed at  9 dpf. After 24  , 48h treatment test drug and std drug statistically 
significant positive effect i.e percentage reduced hyperlipidemia zf lipid levels in the 
blood 24±0.9, 31± 1.2, 40±1.3 and 43± 0.8 and 43±1.1, 63 ± 1, 90 ±1.2 and 95 ±1.3 
for  test  drugs  and  std  drug  respectively.  Hyperlipidemic  control  showed  100% 
elevation of lipid levels. (p<0.001) 
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FIGURE-10 
ASSESSMENT OF LIPID LOWERING EFFECT 
IN ZEBRAFISH LARVAE 
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CHAPTER   VI DISCUSSION 
CHAPTER VI 
DISCUSSION 
The dissertation covers a study on the widely available a member of the family 
Sapinadaceae  is  known  botanically  as  Cardiospermum  halicacabum  L.  called  as 
balloon vine. Cardiospermum halicacabum is a cheap natural and easily available 
plant. It is traditionally known to be useful for the treatment of wide panel of disease 
like rheumatism,lumbago,stiffness of limbs, snake bites, allergy relief, ear ache, back 
ache,fever,stomatchic,rubefacient,demulcent inorchitis and dropsy,haemorrhoids. 
C.halicacabum leaf juice cures the ear ache and for Hemorrhoids .Leaves and stalks 
of the plant are used as diarrhoea and dysentery. .(Patil et al.,2011).(G.Ponmari et 
al.,2011). 
Leaf  reported  to  possess anxiolytic  activity  ,memory  enhancing  activity, 
hypoglycaemic  activity,  fever  with  cough  ,  antihyperglycemic,  antioxidant  and 
antihyperlipidemi activity, central nervous system depression , Antirheumatic activity , 
Anti-inflammatory activity . (Malaviya S et al.,2009) .Seed is used as a fever and as a 
diaphoretic and oral pain relievers. Seed oil have  anticancer activity.( Dhayabaran D 
et al.,2012,Krishna murthy naik.V,et al.,2014). 
Root used as a nervous disease and it also used as emetic, laxative. 
The plant is much more popular in India than any other country of the world 
since antiquity. This could be evidence from the numerous citations laid down in the 
ancient literatures, particularly the Indian scriptures. In India leaves used as food and 
is rich source of nutrition. 
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The economics of this crop evidently proved that as commercial crop. In fact 
the revenue generated by this crop can be further magnified by man folds, if its 
medicinal   applications   are   scientifically   explored   well.   Therefore   research   on 
development of herbal products from the leaves of Cardiospermum halicacabm is 
required to be initiated immediately for exploring the unique potential of this crop 
which would also minimize the menacing wastage of this leaves. It may be further 
envisaged that is merely transportation and marketing facilities including the export 
channels were developed adequately then the revenue generated by this leafy crop 
would easily exceed that generated by any major crop of the country even with a 
present level of traditional agreoconomic practices. Therefore as well coordinated 
effort by the farmers, traders, scientist, technologists, extension workers, physician, 
administrators and policy makers is required to be initiated to boost up the national 
economy as well as the proper exploitation of this for proper therapeutic purpose. 
PHARMAOGNOSTICAL STUDIES 
Morphological and micro morphological examination and characterization of 
medicinal plants have always been accorded due credentials in the pharmacological 
studies.  There  was  no  detailed  pharmacognostical  work  has  been  carried  out 
including botanical identity based on micro morphology in this leaves of this plant. 
The application of morphological studies in drug analysis is pertinent in the 
field of crude drug authentication. It was studied for the leaf. Interpretation of the 
morphological characteristic based on different parameters, for the plant organs give 
a guideline for the diagnosis of the original plant and its adulterants. 
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Color, size, shape, margin, texture, arrangement were observed and 
compared with previous data. Leaves is pubescent or nearly glabrous annual or 
perennial with slender branches climbing by means of tendrillar.Ternately 
bicompound,  biternate  essentially  3  folliate  with  each  part  divided  again  into  3 
leaflets. 
Microscopic techniques help to magnify the fine structure on minute objects 
and there by confirm the structural details of the plant drug. Though the microscopical 
evaluation  cannot provide complete profile,  still it  can  offer  supporting evidences 
which when combined with other analytical parameters can be used to obtain full 
evidence  for  standardization  and  evaluation  of  herbal  drugs.  Consideration  must 
therefore, be given to the types of cells and cell inclusions and the manner in which 
they are distributed in different organ of the plants. 
The leaf is dorsiventral and prominent .T.S of midrib projecting  both  abaxial 
and  adaxially.  The  inner  part  of  the  adxial  cone  includes  a  cluster  of  angular 
collenchyma  cells.Where  as  inner  side  of  abaxial  are  consist  of schlerenchyma 
cells.The palisade is extended up to the shoulders of the cone. The vascular strand is 
fairly prominent and is triangular in shape comprises a cluster of wide circular thin 
walled xylem elements and a thick band of phloem elements. 
Epidermis is fairly large squarish thick walled cells. The abaxial epidermal 
cells are thin, small and elliptical. Para dermal section shows epidermal cells wide 
with highly wavy anticlinal walls and amoeboid outline. The stomata are dense and 
diffuse in distribution and are anomocytic type. The guard cells are elliptical and the 
stomatal pores are slit like. 
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Lamina shows The mesophyll is differentiated into upper band of narrow 
cylindrical  palisade  cells  and  lower zone  of  two  or  three layers  of  lobed  loosely 
arranged spongy parenchyma cells. The lateral veins are conspicuous, straight and 
uniformly  thin.  The  vein  islets  are  distinct  having  straight  vein  boundaries.  Vein 
termination are present  in the islets some places branched once or twice and spread 
within the islets. 
Transverse section of petiole shows two prominent grooves towards upper 
side where as the lower side is round. The epidermis is composed of single layer of 
cells. Chlorenchymatous hypodermis is present. 4-6 collateral vascular bundles are 
present in the ground tissue. The xylem is present upper side and phloem towards 
the lower side. The ground tissue is made up of parenchyma cells 
T.S of rachis shows Polygonal in outline with two winged projections at the 
upper side. Single layer of epidermal cells composed of horizontally flattend cells with 
cuticle. Covering uniseriate multicellulor trichomes are present.   Peripheral layer of 
ground tissue are composed of collenchymatous and chlorenchymatous cells forms 
the hypodermis.  A continuous ring of pericyclic fibres is present in the ground tissue. 
Vascular bundles are arranged in a ring and are collateral. The rest is 
parenchymatous. 
Scanning Electron Microscope (SEM) study of the leaf surface showed the 
presence of  unicellular  trichome and  ranunculaceous  or  anomocytic stomata  and 
their distribution. 
The plant drugs are generally used in the powdered form where the macro 
morphology  is  generally  destroyed,  so  the  diagnosis  of  the  plant  through  the 
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microscopical character is essential. The powdered crude drugs can be identified 
based  on  the  presence  or  absence  of  different  cell  types.  In  the  powdered 
microscopy, we have observed xylem vessels, ranunculaceous stomata, unseriate 
multicellular trichomes, collenchyma, phloem cells, fibers. 
Quantitative microscopy includes certain measurements to distinguish some 
closely related species which are not easily differentiated by general microscopy. The 
stomatal  number  is  the  oldest  technique  but  a  simple  method  of  diagnosis  of 
fragmentary  leaf  parts.  The  stomatal  index  is  the  percentage  in  relation  to  the 
epidermal cells. Both are very specific criteria for the identification and 
characterization of leafy drugs. Vein islet and vein termination number are another 
simple technique for distinguishing fragmentary specimens at specific levels. It is 
used as the distinguishing character for the leaf of the same species or different one. 
Palisade ratio is another criteria for identification and evaluation of herbal 
drugs. This value remains constant within a range for a given plant species and is of 
diagnostic value in differentiating the species. This value does not alter based on 
geographical variation and differs from species to species and that is why it is a very 
useful  diagnostic  feature  for  characterization  and  identification  of  different  plant 
species. 
The  ash  content  of  the  crude  drug  is  generally  taken  to  be  the  residue 
remaining  after  incineration.  If  usually  represents  the  inorganic  salts  naturally 
occurring in the drug and adhering to it, but it may also involve the inorganic matter 
added  for  the  purpose  of  adulteration.  There  is  a considerable  difference  within 
narrow limits in the case of individual drug. Hence ash determination furnishes a 
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basis for judging the identify and cleanliness of a drug and gives information related 
to its adulteration with inorganic matter. The ash or residue yielded by an organic 
chemical compound is a rule to measure the amount of inorganic matter, which is 
present as impurity. In most cases the inorganic matter is present in small amounts 
which  are  difficult  to  remove  in  the  purification process  and  which  are  not 
objectionable if only traces are present. Ash values are helpful in determining the 
quality  and  purity  of  the  crude  drug  in  especially in  powdered  from.  The  acid 
insoluble ash is of more value to detect the earthy matter adhering to the drug. In 
this way one can obtain evidence of the presence of foreign matter, which likely to 
occur with root, rhizomes and also in pubescent leaves. The water soluble ash is 
used to detect the presence of matter exhausted by water. Insufficient drying favours 
spoilage by molds and bacteria and makes possible the enzymatic destruction of 
active principles 
Extractive   values   of crude   drugs   determine   the   amount   of   active 
constituents  in  a  given  amount of  medicinal  plant  material  when  exhausted  with 
solvents. It is employed for that material for which no chemical or biological assay 
method exist. As mentioned in different official books (IP 1996 and BP 1980, BHP 
1990, etc.,) the determination of water soluble and alcohol soluble extractive, is used 
as means of evaluating crude drugs which are not readily estimated by other means. 
The extractions of any crude with a particular solvent yield a solution containing 
different  phytoconstituents.  The  composition  of  these  phytoconstituents  in  the 
particular  solvent  can  be  the  means  of  providing  preliminary  information  on  the 
quality  of  a  particular  drug  sample.  The  water  soluble  extract  values  play  an 
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important role for the evaluation of crude drugs. It can be used to indicate poor 
quality, adulteration with any unwanted material or incorrect processing of the crude 
drug during the drying, storage etc. The alcohol soluble extractive is also indicative 
for the same purpose as water soluble extractive values. 
Loss on drying at 105°C is determined as the presence of excess moisture is 
conductive  to  the  promotion  of  mold  and  bacterial  growth,  and  subsequently  to 
deterioration and spoilage of the drug. 
THE PRELIMINARY PHYTOCHEMICAL STUDIES 
The preliminary phytochemical screening reveals the presence of 
carbohydrates, proteins and amino acids, flavonoids, terpenoids, alkaloids, saponins, 
tannins and phytosterols. Glycosides, volatile oils, fixed oil , mucilage were found to 
be absent. 
Ethanolic extract of the C.halicacabum leaves (EECHL) was prepared and 
dark green viscous residue obtained  13.5%w/v. 
The reaction of drugs in powdered form in ordinary light and with filtered UV 
light  is  importance in  several cases  by the  luminosity  in  UV light  by fluorescent 
analysis. Many flavonoids showed distinctive colors under UV light: Bright yellow (6- 
hydroxyl flavonoids and flavones and some chalcones), dark brown most flavanol 
glycosides, dark may be (isoflavones and flavonols). Hence this parameter can also 
be used as a diagnostic tool for the standardization of herbal drugs for the detection 
of adulterants in crude drugs. (Harbone, JB 1973). 
Total  flavonoid  content  of  EECHL  was  found  to  be  1.06  mg/g  and  total 
phenolic content was found to be 38.05mg/g. 
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Identification of inorganic minerals of the leaves of C.halicacabum by Electron 
Dispersive x-ray Spectrophotometer (EDS) showed the presence of minerals C- 
53.67%, O-44.05%, Mg-0.18%, P-0.36%, Cl-0.18%, K-1.27% Ca-0.28%. (Table-10, 
Fig.). 
HPTLC profile of EECHL was performed and the presence of Pinitol were 
identified and quantified, (0.142mg/100mg). 
PHARMCOLOGICAL STUDIES 
Investigation  on  the  acute  toxicity  of the  ethanolic  extract  of  the  leaves 
showed no mortality and morbidity even under high dose levels (2000mg/k b.w.) 
indicating high margin of safety of the plant extract. (Vijayakumari K, Senthilkumar S., 
2017). 
We perform preliminary toxicological studies of EECHL on the embryo 
and  larvae  of  zebrafish.  Effects  of  compounds  any  possible  retardation  of 
development due to the substance be clearly and distinctly observed. Either mortality 
or incidence of malformation was not observed with 0.5-0.75 mg/ml. Podophyllotoxin 
was used as standard toxin which showed total mortality at 0.01 µg/ml concentration 
(Score  40).  This  observation  showed  no  pronounced  retardation  in  zf  embryo 
development when exposed to normal concentration which showed that EECHL of 
leaf would pose no hazard to early life stages Danio rerio. 
We  performed  larval  toxicity  assay  after  hatching  using  5dpf,  larvae  was 
observed  that  0.5,  0.75  mg/ml  concentration  showed  no  mortality  and  5%,  10% 
mortality were observed at 0.75 mg/ml concentration. The standard podophyllotoxin 
showed 100% mortality at 10 mg/ml concentration. This study showed no significant 
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mortality or malformation in zf larvae at 24 h exposure at normal concentration but 
showed  moderate  toxicity  at  higher  concentration  so  this  evaluation  showed  no 
embryo toxicity or larval toxicity and toxicity was dose dependent. 
When zf larvae 5dpf were fed with 0.1% egg yolk and ORO for imaging at 24 
and 48 h of egg yolk feeding followed by quantitative image analysis through the 
vena caudalis of individual larvae we found that the lipids in zf gut and vasculature 
increased with time and indicated that a time dependent increase in whole larval 
triacyl glycerol content was correlated with the increased level of staining. At 48h of 
feeding blood lipid engorge uniformly it showed that feeding for48h to be selected for 
subsequent experiment after removing egg yolk for 24h and 48h lipids of gut and 
blood vessels were abundant; the lipids were plenty full in the guts and were poor in 
vasculature at 72h after removing egg yolk and the lipid of gut and blood vessels 
were not found at 96h after removing egg yolk. Hence, drug treatment for 24h and 
48h were selected for quantify efficacy. When compounds and food are provided 
simultaneously, a major confounding variable is the impact of a drug on feeding 
behavior such that treatment group. This study design has the advantage that it does 
not require such assays since feeding is performed prior to drug treatment. 
The major previously reported components of EECHL are alkaloids, 
terpenoids, flavonoids, saponins, pinitol. Apigenin and rutin are the predominant form 
of flavonoids and many of the beneficial effects may be attributed with them. Pinitol is 
a cyclitol, a cyclic polyol. It is a known antidiabetic agent isolated from Sutherlandia 
frutescens leaves  and  Bougainvillea.  D-pinitol (3-O-methyl-chiroinositol),  an active 
principle of the traditional antidiabetic plant Bougainvillea spectabilis, is claimed to 
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exert insulin-like effects. Pinitol is a completely non-toxic and common constituent of 
legume plants and is a major component of soybean (Glycine max L Merr). Earlier 
isolated from pine tree the hypoglycemic action and anti-hyperlipidemic effect of 
pinitol have been well established. Clinical trials on the effect of pinitol on glycemic 
control  and  lowering  cardiovascular  risk  factors  in  patients  with  type  II  diabetes 
mellitus have been proved. Pinitol is reported safe and nontoxic as an anti-diabetic 
agent even at high levels (Pavithra R et al., 2017). A stabilized HPTLC method for 
identifying and quantifying pinitol was adopted for this study. 
This study was under taken with the objective of developing an ideal model for 
hyperlipidemia that would closely reflect the natural history and metabolic chacteristic 
of  human  hyperlipidemia  and  respond  to  the  pharmacological  treatments.  The 
developing larval zf are small and translucent, enabling non-intrusive visualization of 
organs and biological processes in vivo with a high resolution. We used a high-fat 
diet egg yolk to feed larvae and develop a zf larval hyperlipidemia model and lipids 
were quantify using ORO staining. In our model EECHL significantly decrease 
lipid levels for 100, 150, 200µg/g 24±0.9, 31±1.2, 40±1.3 for 24 h, 43±1.1, 63±1.3, 
90±1.2% for 48h respectively after treatment (p< 0.001). Human lipid lowering drug 
ezetimibe  (the  Niemann-Pick  C1-like  1  NPC1L1  protein  cholesterol  transporter 
blocker) significantly reduce lipid levels 43±0.8 for 24h and 95±1.3% for 48h after 
treatment.  In  addition  we  also  found  that  there  was  increase  in  heartbeat  of 
hyperlipidemic zf larvae which became normal dose dependently showing that there 
was no cardio vascular complication. 
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It was already reported that ethanolic extract of the leaves of C.halicacabum 
possesses antioxidant and hypolipidemic effects in diabetic rats, which may be 
due   to   the   presence   of   flavonoids,   such   as   apigenin   and   luteolin   in   the 
extract.(Veeramani C et al.,2010). 
In our report also we found significant decrease in lipid levels equivalent to 
standard drug ezetimibe supporting the previous result. We assume that this effect 
may be due to the presence of pinitol. 
We  recommend  further  investigation  in  animal  model  and  clinical trials to 
confirm this potential therapeutic effect. These aspects remain to be studied. 
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CHAPTER VII 
CONCLUSION 
The present investigation highlights the pharmacognostical, phytochemical and 
potential  role  of  lipid  absorption  inhibition  and  cardio  protection  of  the  leaves  of 
Cardiospermum  halicacabum  belonging  to  the  family  Sapinadaceae,  a  widely, 
easily available edible plant. Ethnomedical information revealed that it was used in 
various  ailments  including,  rheumatoid  arthritis,  GI  disease,  diuretic,  stomachic, 
rubefacient,  ear  ache,  back  ache,  fever  ,lumbago,  nervous  disease,  demulcent, 
dropsy etc. The economic potentiality of this cash crop remains neglected by the 
scientists,  technologists,  physician,  traders,  administrators,  policymakers,  farmers, 
etc. 
The morphological evaluation showed the adherence of general characters to 
the family. 
Detailed  microscopical  characters  of  the  leaves  showed  the  usual  leaf 
characters,  vascular  bundle,  ranunculaceous  stomata,  non-glandular,  glandular 
simple,   unicellular   or multicellular,   unbranched uniseriate   trichomes   on   both 
epidermis,  The  inner part  of  the  adaxial  cone includes  a  cluster  of  angular 
collenchyma cells and inner part of abaxial cone consist of schlerenchyma cells. 
Scanning Electron Mciroscope (SEM) showed the  trichomes  and ranunculaceous or 
anomocytic stomata and their distribution. 
Petiole  shows two prominent grooves towards upper side where as the lower 
side. epidermis is composed of single layer of cells. Powder microscopy, microscopic 
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schedules vein islet and vein termination number, stomatal number and stomatal 
index, palisade ratio, physicochemical parameters ash values, extractive values, loss 
on drying were determined and presented. 
Preliminary phytochemical screening showed the presence of carbohydrates, 
proteins,  amino  acids,  alkaloids,  saponins,  flavonoids,  tannins,  terpenoids  and 
absence of mucilage, volatile oil, fixed oil. 
Identification of inorganic minerals of the leaves of C.halicacabum  by Electron 
Dispersive x-ray Spector photometer (EDS) showed the presence of minerals C- 
53.67%, O-44.05%, Mg-0.18%, P-0.36%, Cl-0.18%, K-1.27% Ca-0.28%. 
Total flavonoids and total phenolic contents were determined and presented 
1.06 mg/g, 38.05 mg/g respectively. 
HPTLC profile of the ethanolic extract of the leaves of C.halicacabum was 
presented. Presence of Pinitol was confirmed and quantified as 0.142 mg/100mg. 
“The  3R’s  (Reduction,  Refinement,  Replacement)  of  ethical  principle  was 
implemented  that  help  to  minimize  harms  to  animals  used  in  science.  In  our 
investigation we used zebra fish larvae which is a emerging novel preclinical in vivo 
model  that  support  rapid  decision  making  in  the  early  phases  of  drug  discovery 
process. It is amenable to medium to High Throught Screening (HTS) because of 
numerous advantages. The properties of the genome of zf have established it as an 
excellent model system that is relevant to studies of human diseases. 
We performed preliminary toxicological studies of EECHL on the embryo and 
larvae of zebrafish and found no pronounced retardation in zf embryo development 
when exposed to normal concentrations (0.5 to 2µg/ml) which showed that EECHL of 
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leaf  would  pose  no  hazard  to  early  life  stages  Danio  rerio  but  standard  toxin 
podophyllotoxin showed 100% mortality at 0.01µg/ml. 
Larval toxicity study was carried out on zf larvae of 5dpf , it was observed that 
there was no mortality in 0.5 and 0.75 mg/ml concentrations. 5, 10, 100% mortalities 
were observed in 1,2,mg/ml of EECHL and 0.5µg/ml of podophyllotoxin respectively. 
Previous Investigation on the acute toxicity of the ethanolic extract of the leaves 
showed no mortality and morbidity even under high dose levels (2000mg/kg b.w.) 
indicating high margin of safety of the plant extract. 
We  used  a  high-fat  diet  egg  yolk  to  feed  larvae  and  develop  a  zf  larval 
hyperlipidemia model. In our model EECHL significantly decrease lipid levels at 100, 
150,  200µg/ml  dose  dependently  comparable  to  the  standard  drug.  (p<  0.001). 
Human lipid lowering drug ezetimibe (the Niemann-Pick C1-like 1 NPC1L1 protein 
cholesterol  transporter  blocker)  significantly  reduce  lipid  levels  after  treatment.  In 
addition we also  found that there was increase in heartbeat of hyperlipidemic zf 
larvae which became normal and without any morphological changes (heart rate, 
cardiac enlargement, blood flow, etc.) dose dependently in EECHL treated showing 
no CVS complication. This conventional zebrafish hyperlipidemia model is predictive, 
easily available, economic with a short testing duration and could speed up lipid 
lowering drug research development. Further investigations are needed to elucidate 
potential biochemical and molecular mechanisms of this biological effect. 
The plant leaf possesses several flavonoids such as apigenin, luteolin and the 
cyclitol pinitol which are reported as the antilipidemic principles. The hypoglycemic 
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action and anti-hyperlipidemic effect of pinitol has been well established. The 
beneficial antihyperlipidemic activity may be attributed to pinitol. 
These results suggest that ethanolic extract of the leaves of C.halicacabum 
(EECHL) exerts in zebrafish larvae a therapeutic effect and that may be used as 
advantage in therapeutic approach. Further experiments are required to prove the 
mechanism and advantage of EECHL over other drugs. 
The hypercholesterolemic  zebrafish can be used as a low-cost andinformative 
model for testing new drug candidates and for investigating mechanisms of action. 
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